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CHAPTER I GENERAL INTRODUCTION
The various sections of this Thesis relate to 
investigations aimed at understanding the mechanism 
by which morphine-like compounds affect the central 
nervous system. The technique of microelectrophoresis 
enabled examination, at the single cell level, of the 
effects of opiates on the various firing patterns of 
central neurones. Attempts to correlate this 
information with the known central effects of these 
compounds given systemically have been made. These 
investigations led to studies of the interaction of 
opiate compounds with receptors for acetylcholine 
and studies on these receptors alone have also been
carried out.
2CHAPTER II - METHODS
A. ANIMAL PREPARATION
Cats of either sex weighing 2.5-3.5 kg were 
anaesthetized with pentobarbitone sodium 35 mg/kg I.P. or 
a-chloralose 50-60 mg/kg I.P., or were decerebrated by mid­
brain coagulation (Crawford & Curtis, 1966) under halothane 
anaesthesia. The type of anaesthetic employed depended on 
the particular investigation and is referred to in Results. 
Pentobarbitone anaesthesia was maintained with I.V. doses of 
a 10 mg/ml solution. Maintenance doses of chloralose were 
seldom needed.
Midbrain coagulation for the preparation of decerebrate 
animals was performed using a Wyss coagulator by passing a high 
frequency (500 kHz) current (35 mA for 10 secs) between 
adjacent pairs of coated electrodes. These were inserted 
stereotaxically to an intercollicular position and the whole 
tegmentum destroyed at this level.
In all investigations the temperature of the animals 
was maintained at 36-38°C by a heating pad controlled by a 
probe placed between the rib cage and the right scapula.
Blood pressure was monitored continuously using a Statham 
pressure transducer (P23 Bd).
To minimize brain movements as a result of respiratory 
excursions and to abolish possible reflex movements from elec­
trical stimulation of the forepaws and noxious heating of the 
in thalamic and substantia gelatinosa experiments 
footpad, animalsy\were paralysed with gallamine triethiodide
(4.0 mg/kg I.V. initially and maintained with 2.0 mg/kg 
every 30 mins), and artificially ventilated (38 strokes/min).
3The stroke volume was adjusted to maintain the continuously 
monitored end tidal CC^ level at 3.9 - 4.1%.
In thalamic experiments a bilateral pneumothorax was 
created as a further measure to reduce brain movements.
(a) Spinal Cord Preparation
The left external radial vein, the right common 
carotid artery and the trachea were cannulated. Follow­
ing a midline incision of the dorsal skin over the lumbar 
region, the laminae of each lumbar vertebra were removed 
progressing in a caudal-rostral direction. In most 
experiments the spinal cord was sectioned at the lower 
thoracic level following infiltration with 1% procaine 
solution. The dural sac was opened dorsally and, for 
investigations on Renshaw cells, the seventh lumbar and 
first sacral ventral roots were cut and the proximal 
ends mounted on platinum stimulating electrodes. A
platinum ball electrode placed on the dorsal surface of 
monitored incoming volleys and the exposed cord the spinal cord/\was immersed in paraffin oil (BP) in a
pool formed by the dorsal skin flaps and the pool temper­
ature maintained at 37°C by constant heating. A coil of 
silver chloride-coated silver wire covered with gauze 
impregnated with saline was sutured into adjacent muscle 
and served as a reference electrode. Small holes in the 
pia mater were made with fine forceps at sites appropriate 
for electrode entry.
(b) Thalamus Preparation
Following chloralose anaesthesia, the left external 
radial vein, left femoral artery and the trachea were 
cannulated. The animal's head was then positioned in a 
stereotaxic head frame and the cranium exposed by a midline
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Fig ._____1: Diagram showing arrangement of electronic
apparatus for extracellular recording and drug administration.
incision. A small hole approximately 8 mm in diameter 
and centred on Horsley-Clark "AP + 7.0" co-ordinate and 
15 mm to the left side of the midline suture was made 
with a dental drill. The exposed dura was protected 
from drying by covering the exposed dural surface with 
small pieces of polythene.
B. EXTRACELLULAR RECORDING TECHNIQUES
(a) Apparatus for Recording Extracellularly
Electrical potential changes in the extracellular 
environment near single neurones were recorded from the 
centre barrel of seven or five barrel micropipettes.
This barrel contained 4 M NaCl into which was inserted 
a silver chloride coated silver wire which was surrounded 
in a medium of saline impregnated agar and encased in 
polythene tubing.
Conventional recording techniques were employed and 
a diagrammatic outline of the circuit for recording is 
shown in Fig. 1.
The potentials were led to a first stage cathode 
follower, two preamplifier stages (time constants 0.003 
sec) and were displayed on an oscilloscope. The output 
from the cathode follower was also connected to a second 
amplifying system, the output of which was used to trigger 
a pulse generator. The size of action potentials trigger­
ing this generator was selected by using a voltage dis­
criminator, and the derived standard pulses were counted 
by a ratemeter and the frequency then displayed on a pen 
recorder. To ensure accurate counting,both the amplified
5signal and derived pulses were compared on the one 
oscilloscope. Synaptic responses were analysed in some 
cases by preparing peristimulus time histograms. This 
was performed with the aid of a small Ortec computer 
(128 bins).
(b) Location and Identification of Neurones 
(i) Spinal Cord
Dorsal horn interneurones were located by four 
methods -
1. Spontaneous firing,
2. Firing produced by continuous ejection of 
an amino acid excitant from the advancing 
electrode,
3. Firing in response to stimulation of branches 
of the ipsilateral sciatic nerve.
Dorsal root volleys produced by such stimulation 
were monitored and the stimulus intensities 
necessary to activate the neurone were measured 
relative to that of the threshold of the largest 
fibres. Dorsal root volleys indicating a con­
duction velocity greater than 30 m/sec have been 
classed as derived from M  fibres, and lesser 
velocities as derived from A6 fibres (Gasser and 
Grundfest, 1939). No C fibres were stimulated.
4. Firing in response to "natural stimuli" - 
either radiant heat or deflection of hairs. 
Radiant heat was produced by means of a lamp 
focussed to a spot approximately 3 mm in 
diameter on one of the digital pads. There 
is evidence that when skin temperature exceeds
645°C the input to the spinal cord from the 
irradiated area is almost exclusively from 
thermal nociceptors (Beck, Handwerker and 
Zimmermann, 1974). Skin temperature was 
monitored by a thermistor placed at the edge 
of the irradiated area and was displayed on 
a pen recorder together with cell firing 
produced by this stimulus. On these pad 
areas the temperature attained by 20 to 30 
seconds of irradiation was between 47°C and 
52°C and the latency of cell firing was 5-15 
seconds. Cells firing with a shorter 
latency were excluded as the temperature 
reached at these times was unlikely to 
activate nociceptors.
Non-noxious stimulation, movement of 
hairs in the foot region, was produced by a 
continuous jet of air from a small polythene 
tube mounted on the oscillating arm of an 
electrical relay activated at 4 Hz by a Grass 
S8 stimulator. Both these types of "natural" 
stimulation were controlled by timing units 
(Venner) and the duration of their effect 
could be selected as required.
Renshaw cells were located by the firing 
in response to antidromic stimulation of 
the seventh lumbar and first sacral ventral 
roots, and by excitation in response to the 
electrophoretic ejection of acetylcholine.
7(ii) Medial Thalamus
Neurones of the centre median, lateralis 
posterior and parafascicularis nuclei were 
approached at 45° to the vertical using stereo­
taxic methods. Single neurones were located 
by responses to electrical stimulation of the 
forepaws (Albe Fessard and Rougeul, 1958).
Current pulses, 10-15 mA, 0.1 m/sec duration and 
0.2 - 1.0 Hz, were applied to pairs of fine 
uninsulated needles implanted in the main foot 
pad of each forepaw. Monitoring of the radial 
and ulnar nerves demonstrated that this type of 
stimulation activated small diameter slow- 
conducting fibres as well as the larger faster 
conducting fibres.
Difficulty was experienced in recording from 
single cells. In several instances although 
only one neurone was evoked by this method of 
peripheral stimulation, the ejection of an amino 
acid excitant activated many neurones. During 
spontaneous firing it was common for several 
neurones to fire synchronously. Cell firing 
evoked by electrical stimulation was also 
measured by preparing peristimulus time histograms.
C. DRUG ADMINISTRATION
(a) Microelectrophoretic Methods
This technique involves the ejection of ionized 
compounds contained in glass micropipettes into the
8extracellular environment of single neurones. This 
procedure has been described in detail by Curtis (1964).
(i) Preparation of Micropipettes
Five or seven barrel micropipette assemblies 
were drawn out in a vertical pulling device and 
the tips broken under microscope observation to 
the required dimensions, most commonly 5-6 pm, by a 
fine glass rod mounted on a hydraulic manipulator 
(De Fonbrune, Paris). Aqueous solutions of the 
salts of the compounds to be ejected electro- 
phoretically were centrifuged (1600 g) for 10 
minutes and pipetted into individual barrels of 
the micropipette assembly. Following centrifugation 
(1600 g, 13 mins) which propelled the solutions to 
the tip, the resistance of each barrel was measured 
and the micropipettes stored in a bell jar until 
experimentation. Electrodes were used within 3 
days of preparation.
(ii) Solutions
The solutions used in the investigations of this 
thesis, together with concentrations (and pH if 
adjusted) are listed in Table I.
(iii) Some Considerations On The Use of Microelectrophoresis 
The amount of a compound ejected electro- 
phoretically is a function of the current that is 
passed between the micropipette barrel and the nervous 
tissue. This "ejecting current" was supplied by the 
polarizer circuit shown in Figure 1 and current 
magnitude could be varied as required. A retaining 
voltage (commonly 0.5V) of opposite polarity to that
TABLE I SOLUTIONS FOR ELECTROPHORETIC ADMINISTRATION
Compound Concentration pH (if adjusted)
Acetylcholine Cl 0. 5M
Acetyl-ß-Methylcholine cl 0. 5M
Atropine SO^ lOmM in 0.1M NaCl
a Bungarotoxin 1.5 x 10 g/ml
Dextrorphan tartrate 0.1M
Dihydro-ß-erythroidine lOmM in 0.1M NaCl
■y-amino butyric acid (HC1 0.5M 3.0
Glycine (HC1) 0.5M 3.0
Levallorphan tartrate 0.1M
Levorphanol tartrate 0.1M & 25mM in 0.1M NaCl
Morphine SO^ 0.07M
Nalorphine HBr 0.1M
Naloxone HC1 0.1M
Nicotine HCl 0.2M 7.5
Oxymorphone HCl 0.1M
Physostigmine salicilate lOmM in 0.1M NaCl
Sodium L-aspartic acid 0.5M 6.8
Sodium L-glutamic acid 0.5M 7.2
Sodium DL-homocysteic acid 0.2M 7
9for ejecting the compound was applied continuously 
to each drug containing barrel.
While the concentration of an ejected compound 
in the extracellular environment cannot be accurately 
determined, it is possible to compare, on the basis 
of ejecting currents, the relative potency of one 
compound on different types of neurones or of 
several compounds on one type of neurone (Duggan, 
1974) .
A considerable proportion of the investigations 
described in this thesis is concerned with reduction 
by a locally or intravenously administered compound 
of neuronal firing in response to a chemical, 
physiological or artificial stimulus. It must be 
demonstrated by the use of adequate controls that 
such an effect, particularly when observed over an 
extended period of time, was a direct consequence 
of the compound administered and not of variation of 
physiological conditions. Similarly recovery must, 
when possible, be observed. The changes in blood 
pressure and respiration consequent upon intravenous 
administration of morphine-like compounds are well 
known, and any resultant tissue movement may well 
lead to alterations in extracellular recording 
parameters caused by alteration in pipette to cell 
distances. The artifactual changes produced by 
these effects when electrophoretic ejection is 
occurring are important when concentrations at 
receptor sites are considered. For these reasons 
it was essential to observe alternately the effect
10
believed susceptible to the administered compound 
concommitantly with an effect thought not to be 
susceptible. For example, to show that the 
antagonism by electrophoretically administered 
naloxone of the excitation of a Renshaw cell induced 
by morphine was a true effect and not due to increas­
ing pipette-cell distances (a situation that would 
"dilute" the effect of morphine anyway), responses 
to an amino acid excitant were elicited alternately 
with those of morphine. Similarly, the effects of 
opiates on the responses of dorsal horn interneurones 
to noxious stimulation were always determined in the 
presence of responses to "non-noxious" stimulation. 
When testing for the anticholinergic actions of the 
snake neurotoxins, an amino acid excitant was alter­
nately ejected with acetylcholine.
The use of a retaining voltage results in a 
progressive lowering of drug concentrations in the 
tip of a micropipette. Compounds were therefore 
administered for fixed times and at fixed intervals 
and responses elicited were only considered control 
responses when they were observed to be reproduceable 
on successive ejections.
(iv) Two-electrode Experiments
In an endeavour to reveal effects of electro­
phoretically ejected opiates on the responses of 
dorsal horn interneurones to noxious stimulation of 
the footpads, an attempt was made to administer 
drugs to the dendritic regions, as distinct from 
the soma, of single neurones. This involved the
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apposition under microscopic observation of the tips 
of a five and a seven barrel micropipette just above 
the dorsal surface of the spinal cord, and noting 
the respective manipulator co-ordinate readings.
The seven barrel micropipette, containing drugs for 
influencing the dendritic processes, was advanced 
vertically into the cord, until neuronal activity as 
a result of an ejected amino acid excitant was first 
encountered. These neurones were usually 0.8-1.0 mm 
below the dorsal surface of the cord and deposits 
of pontamine sky blue subsequently showed them to 
be located in Rexed lamina I (Rexed, 1954). The 
micropipette was then advanced 50-200 pm ventrally 
so as to lie in the region corresponding to Rexed 
laminae II or III, the substantia gelatinosa. As 
well as containing small neurones, this region is 
considered to contain the dendrites of more ventrally 
situated neurones (Szentagothai, 1964). It was 
from these lamina IV and V neurones that single 
neurone recording was achieved with the five barrel 
micropipette. The five barrel micropipette, the 
precise position of which relative to the other was 
known, was then advanced into the cord at 18° to the 
vertical, passing 200-350 pm beneath the tip of the 
seven barrel micropipette. When approaching this 
position, neurones were located by firing evoked 
chemically or synaptically (See Fig. 23). Neurones 
were accepted for testing if they were located within 
600 pm of the substantia gelatinosa pipette and if 
they were excited by both noxious and non-noxious
12
Stimulation.
(b) Administration By Pressure
(i) Pharmacology of Snake Toxins
When it became apparent that Renshaw cell
responses were not influenced by snake toxins
administered electrophoretically, administration by
pressure was used in case the lack of response was
due to failure of electrophoretic administration.
Cobra neurotoxin and a-bungarotoxin was supplied by
Professor C.Y. Lee having been purified from the
whole venoms of Naja naja atra and Bungarus
multicinctus according to the procedure described
previously (Lee et al., 1968; Lee et al., 1972).
The several methods of administering the compounds
by pressure are summarized below -
- 21. ct-Bungarotoxin (1.5 x 10 g/ml solution)
By applying air pressure of up to 300 mm Hg 
to the toxin containing barrels of seven 
barrel micropipettes of tip diameters 5-8 urn. 
The pressure of air in the system was 
measured with a mercury manometer.
- 22. Cobra Neurotoxin (0.05, 0.5 or 1.5 x 10 )
g/ml solution).
By applying a pressure of up to 300 mm Hg 
to a single toxin-containing micropipette of 
tip diameter 8-15 pm cemented to a 5-barrel 
micropipette assembly which projected 30-50 
pm beyond the tip of the toxin containing 
pipette (A "parallel" electrode, Curtis, 1968).
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By applying a pressure of up to 300 mm Hg 
to the toxin containing barrel of 5-barrel 
micropipettes with relatively large tips 
(7-10 \im) .
By ejecting relatively large amounts of 
toxin from a single micropipette of tip 
diameter 50-80 pm at distances of 1*2-20 mm 
from Renshaw cells from which records were 
being obtained using a separate 5-barrel 
micropipette. From the changes in the 
level of solution within the pipette,the 
volumes administered were estimated to be 
between 10 and 30 pil.
Unlike ejection by electrophoresis where 
the current provides a measure of the amount 
of substance being administered from the tip, 
ejection by pressure cannot be quantified.
In determining whether toxin was being 
ejected the following observations could be 
made
A reversible change in action potential 
amplitude on applying pressure to the toxin 
containing barrel.
An increase in spontaneous firing immediately 
following ejection,presumably a result of 
mechanical disturbances in the tissue caused 
by solution ejection.
Changes in cell firing following pressure 
applied to an adjacent barrel of the micro­
pipette assembly. This was either
14
excitation when an amino acid excitant was 
ejected or a reduction in the response to 
acetylcholine or to a ventral root stimulus 
following application of pressure to a 
barrel containing dihydro-ß-erythroidine.
These controls, while not being strictly 
adequate for ejection from the toxin con­
taining barrel, gave an indication of the 
extent to which tissue debris may have 
been occluding the whole micropipette 
assembly (see Andersen & Curtis, 1964). 
Microscopic observation of ejection into 
oil or of streaming of a talc suspension 
in the vicinity of the electrode tip when 
pressure was applied to the toxin- 
containing barrel both before and after 
insertion into the spinal cord.
The purified toxins were iodinated by 
Dr. I. Hendry of this Department according 
to the method of Berg et a_l. , (1972) and
were ejected in the vicinity of Renshaw 
cells by pressures of up to 300 mm Hg from 
single micropipettes of tip diameter 15-25 ym. 
The precise location of Renshaw cells was 
determined by prior penetration of the cord 
with a micropipette while stimulating 
ventral roots. The amount and rate of 
ejection was controlled by directly observ­
ing the fall in the level of the toxin 
within the pipette. This had been
15
approximately calibrated by comparison with 
levels in similar pipettes containing 0.5 
and 1.0 pi of water. At each injection 
site, between 0.06 and 0.1 pi of neurotoxin 
was expelled. Partial blockage of the tip 
of the micropipette by tissue was common as 
evidenced by variations in the pressure 
necessary to expel this volume over a period 
of 1-3 minutes. As well as injections 
adjacent to Renshaw cells, neurotoxin was 
also deposited in the dorsal horn during 
withdrawal of the electrode. A series of 
spaced (3-7 mm) injections were made 
sufficient to avoid cross-contamination 
for diffusion times up to 7 hours.
(c) Intravenous Administration
Solutions administered intravenously were:
Morphine sulphate 5 or 10 mg ml ^
Naloxone hydrochloride 0.5 or 1.0 mg ml  ^
Levorphanol tartrate 1.0 mg ml ^
Levallorphan tartrate 0.5 or 1.0 mg ml ^
All solutions were made up in .165 M NaCl.
Because of the circulatory effects of morphine, this 
compound was administered in a series of gradually in­
creasing doses (Schmitt and Livingston, 1933). An 
initial dose of 0.5-1.0 mg kg  ^was usually given and 
succeeding doses, at 5 to 10 minute intervals. All 
intravenous compounds were administered into the left 
external radial vein.
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D. HISTOLOGY
(a) Dye Marking Techniques
In many experiments the site of extracellular 
recording of a particular cell was marked by ejecting a 
dye electrophoretically. The dye solutions used were 
Pontamine Sky Blue, 2% in 0.5 M sodium acetate (Hellon, 
1970), and Acid Fast Green, saturated solution in 2 M 
NaCl (Thomas and Wilson, 1965). Both dyes were ejected 
as anions, Pontamine Sky Blue at 4 pA for 5 mins and 
Acid Fast Green at 5 pA for 10 mins.
At the conclusion of each thalamic experiment a 
mounted scalpel blade replaced the micropipette assembly 
in its holder and was lowered into the exposed cerebrum 
at distances of about 3 mm both caudal and rostral to 
the site of the electrode track. Once the entire brain 
was removed, these incisions enabled removal of a block 
of tissue containing the appropriate area of thalamus and 
permitted the cutting of sections in approximate Horsley 
Clarke frontal planes. This was trimmed and fixed in 
10% formal saline for 3 days. The fixed block was 
then mounted on a freezing microtome and coronal sections 
50 pm thick were cut and examined microscopically for 
the small dye spots. Two pontamine sky blue spots were 
deposited, one at the site of recording and another 
3.0 mm superficial and it was common to find both spots 
within 3 or 4 sections of each other. The sections were 
blotted flat onto a glass slide and kept moist with 
distilled water. A photographic enlargement of the 
unstained section was then made and onto it were marked
17
the positions of the dye spots.
At the conclusion of spinal cord experiments, a 
centimetre length of cord was removed containing an Acid 
Fast Green spot at the site of extracellular recording 
in the vicinity of lamina IV or V and a Pontamine Sky 
Blue spot in the substantia gelatinosa region. The 
tissue was then fixed, sectioned and photographed as 
for thalamic tissue.
(b) Autoradiography
As this technique requires that the fixation of
tissue be more thorough than that obtained by immersing
the tissue block in formal saline, the anaesthetised
125animals, injected intraspinally with I-labelled snake 
neurotoxins,were killed by bleeding from an incision in 
the right atrium immediately following the start of the 
perfusion of the spinal cord with 320 mOsM Phosphate 
buffer, pH 7.4 (Karlsson and Schultz, 1965) containing 
4% paraformaldehyde and 1 mM CaC^. This was via a 
cannula in the thoracic descending aorta, both common 
iliac arteries being ligated. The fixed cord was 
divided into blocks of 4.5 to 7 mm, each being approx­
imately centred on an injection site. Light microscopy 
autoradiography was performed by Dr. I. Hendry and each 
tissue block was embedded in paraffin and serial sections 
of 5 pm were prepared.
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CHAPTER III - STUDIES WITH MORPHINE-LIKE COMPOUNDS
A. EFFECTS OF OPIATE AGONISTS AND ANTAGONISTS ADMINISTERED 
NEAR THE SOMA OF SPINAL NEURONES
Introduction
Chemical synapses are a possible site of action for 
centrally active compounds. Thus many pharmacological, 
biochemical and anatomical investigations have attempted to 
relate the central effect of morphine-like compounds (opiates) 
to effects on specific neurotransmitter systems.
Substantial evidence has been obtained for the existence 
of discrete "opiate receptors", the bulk of this information 
being derived from in vitro studies of the binding of radio- 
actively-labelled opiate compounds to homogenates of brain 
tissue (Goldstein, Lowney and Pal, 1971; see Snyder, Pasternak 
and Pert, 1975). One component of this binding, termed 
"stereospecific", is believed relevant to the interactions of 
systemic opiates. Stereospecific binding in these experi­
ments is defined as the difference in displacement of a 
labelled opiate compound by high concentration of an active 
opiate and that by an inactive isomer (see Goldstein et: al.
1971). Several lines of evidence substantiate the relevance 
of these receptors; opiate compounds compete with a labelled 
compound in a manner related to their relative pharmacological 
potencies (Pert and Snyder, 1973b; Wilson, Rogers, Pert and 
Snyder, 1975) and, of a wide range of compounds tested, only 
those classed as having opiate activity were able to compete 
for binding sites to a significant extent (Pert & Snyder, 1973a).
Although subcellular localization of these "opiate
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receptors"has shown them to be associated with synaptic 
membranes (Pert, Snowman & Snyder, 1974), the precise 
relationship of these receptors to presynaptic or post- 
synaptic structures has yet to be determined. Additional 
studies (Snyder, Pasternak & Pert, 1975) have suggested that 
a consistent relationship between the levels of a particular 
synaptic transmitter and the amount of opiate receptor bind­
ing does not exist and that selective lesions aimed at 
reducing the levels, predominantly of one probable transmitter, 
does not alter the magnitude of binding, despite large 
decrements in the levels of that transmitter (Kuhar, Pert & 
Snyder, 1973). Such studies would indicate that the opiate 
receptor is not a unique component of axons or nerve terminals 
of any one of the transmitter systems.
An ever increasing body of information suggests that 
morphine-like compounds have actions at central receptors 
for acetylcholine. This work was prompted initially by the 
finding that in the guinea pig ileum preparation, the reduction 
by morphine of stimulation-induced contractions was accompanied 
by decreased acetylcholine release (Paton, 1957). There is 
evidence that morphine-like compounds increase the steady-state 
levels of acetylcholine in the central as well as the peri­
pheral nervous systems. (Crossland & Slater, 1968; Giarman 
& Pepeu, 1962; Morris, 1961).
The reduction by morphine of the release of acetylcholine 
from brain tissue into cerebrospinal fluid (Beleslin & Polak, 
1965; Crossland & Slater, 1968; Jhamandas, Phillis & Pinsky, 
1971; Sharkawi & Shulman, 1969) suggests that the increased
acetylcholine levels in the tissue are a result of interference with 
its release. An increase in the synthesis of acetylcholine
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following morphine has not been demonstrated (De La Lande and 
Bentley, 1955; Morris, 1961) and neither has any inhibition 
of brain cholinesterase activity been detected (Ettinger &
Gero, 1966; Dewey, Harris, Howes, Kennedy, Nuite & Hayhurst, 
1969). Furthermore, the depletion of cerebral acetylcholine 
by hemicholinium was prevented by doses of morphine too low 
to enhance acetylcholine levels themselves, an effect antagonised 
by nalorphine and naloxone (Domino & Wilson, 1973). Clouet 
& Williams (1974), employing in vitro methods, have found that 
morphine and some related compounds reduced the acetylcholine 
release from synaptosomal preparations of rat brain in a manner 
generally related to their relative antinociceptive potencies.
Phillis, Mullin & Pinsky (1973) have recently shown that 
morphine enhances acetylcholine release from the cerebral 
cortex in unanaesthetized cats. In similar experiments on 
mid-pontine-pretrigeminal cats, Yaksh & Yamamura (1973) showed 
that morphine blocked acetylcholine release from the arti­
ficially perfused caudate nucleus, an effect antagonized by 
naloxone.
There are other lines of evidence that morphine and other 
opiate analgesics have effects at receptors for acetylcholine. 
Bhargava & Way (1972) have shown that di-isopropyIfluoro- 
phosphate (DFP), a potent acetylcholinesterase inhibitor, 
strongly enhances morphine analgesia. Other cholinesterase 
inhibitors such as physostigmine and neostigmine also 
potentiate analgesia (Slaughter & Gross, 1940; Harris, Dewey, 
Howes, Kennedy & Pars, 1969; Saxena & Gupta, 1957; Szerb,
1957). Oxotremorine, a muscarinic agonist (Cho, Haslett & 
Jenden, 1962) is more effective than morphine in producing 
inhibition of tail-flick in mice and was only weakly antag­
onized by naloxone (Harris et al., 1969; Ireson, 1970;
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Pleuvry & Tobias, 1971; Howes, Harris, Dewey & Voyda, 1969).
These latter findings suggest that opiates increase 
activity at cholinergic synaptic regions while inhibition of re­
lease was the mechanism proposed by the literature cited earlier.
Investigations at sites of cholinergic transmission in
the peripheral nervous system have shown that opiates have
effects on synaptic processes. Morphine has a depressant
action on neuromuscular transmission (Soteropoulos &
Standaert, 1973). Pinsky & Frederickson (1971) and
Frederickson & Pinsky (1971) demonstrated that the release of
acetylcholine in the rat phrenic nerve-diaphragm and frog
sartorius preparations was decreased by morphine. No
with specific antagonists
antagonism of these effects^ or correlation with analgesic 
potency was observed by Bell & Rees (1974) however, and it can 
reasonably be concluded that effects at the neuromuscular 
junction are not related to effects at stereospecific sites.
Contractions of the electrically stimulated guinea pig 
ileum strip are blocked by morphine (Schaumann, 1957), and
Paton (1957) has further demonstrated that this effect is 
closely related to a reduction of acetylcholine released into 
the organ bath following each stimulus. This preparation has 
been widely used to demonstrate antagonism of morphine effects 
by antagonists, the production of tolerance and the close 
correspondence of the potencies of compounds with their 
analgesic potencies (Kosterlitz & Watt, 1968; Gyang & 
Kosterlitz, 1969). The complex organization of the mural 
plexus of nerve cells within the ileum however makes these 
observations difficult to interpret and difficult to relate 
to effects on single central neurones. In cardiac tissue, 
Kennedy & West (1967) have also proposed an inhibition of
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acetylcholine release by morphine.
Studies of the phenomenon of tolerance to and dependence 
upon opiates have also implicated a role for cholinergic mech­
anisms in these processes (Paton, 1963). Several reports have 
found that cholinergic agonists inhibited, while antagonists 
exacerbated the withdrawal symptoms of dependent animals 
(Grumbach, 1969; Brase, Tseng, Loh & Way, 1974, but see 
Jhamandas & Dickinson, 1973). A postsynaptic sensitizing 
action of morphine has been suggested,from studies in the 
peripheral nervous system, as the basis of these phenomena 
(Pollock, Muir & MacDonald, 1972; Muir & Pollock, 1973; but 
see Haycock & Rees, 1973).
In summary then, the literature concerning the interaction 
of morphine-like compounds with cholinergic synaptic processes 
does not suggest one particular mode of action, and although an 
inhibition of acetylcholine release is held to be an important 
effect, at least in the peripheral nervous system, there are 
many reports casting doubt on whether this mechanism is a 
sufficient explanation for all of morphine's actions.
Using microelectrophoretic techniques, cholinoceptive 
neurones have been found in many regions of the mammalian 
central nervous system (for reviews see McLennan, 1970;
Phillis, 1970; Krnjevic, 1974) but as yet there is good 
evidence for cholinergic transmission at only one site - the 
synapses between motoneurone axon collaterals and Renshaw 
cells (Eccles, Fatt & Koketsu, 1954: Curtis & Eccles , 1958).
Felpel, Sinclair & Yim (1968; 1970) provided the first
published account of the effects of morphine on Renshaw 
cell activity. In an earlier study, Kruglov (1964) had 
observed that intravenous morphine 5-10 mg kg reduced re­
current but not direct inhibition of a monosynaptic spinal
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reflex, an effect which was attributed to impaired activity 
at the axon collateral-Renshaw cell synapses. Felpel et al. 
(1968; 1970), however found that Renshaw cell discharges
evoked by ventral root stimulation or by intravenous nicotine 
were not significantly depressed by morphine, despite the 
reduction in recurrent inhibition and concluded that the 
effect of morphine could not be ascribed to an action at 
this site.
Subsequently, Curtis & Duggan (1969), investigating the
nature of the transmitter mediating inhibition at motoneurones,
found that intravenous doses of morphine given in divided
doses to a total of 50 mg kg  ^reduced direct as well as
recurrent inhibition in a roughly parallel fashion. By
demonstrating, in addition, morphine's antagonism of the
inhibitory actions of glycine, when both substances were
administered electrophoretically, they suggested that if a
glycine-like transmitter mediated motoneurone inhibition
then this might explain the reduction of both
inhibitiontypes of reflex-by morphine.
In a similar, but later investigation (Duggan & Curtis, 
1972),the same workers examined the effects of electro- 
phoretically and intravenously administered morphine on the 
latencies of Renshaw cell discharges following ventral root 
stimulation. They found that electrophoretically administered 
morphine increased both the latency and the number of individual 
action potentials following a ventral root stimulus. This 
latter effect, which was also an effect produced by acetyl­
choline and DL-homocysteate, they interpreted as a postsynaptic 
effect of the alkaloid. The increase in latency of each 
action potential was likened to the effect seen with
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hemicholinium (Quastei & Curtis, 1965; Lodge, Curtis &
Craig, 1975) and was therefore suggested to be a presynaptic 
effect, presumably resulting from an interference by morphine 
of acetylcholine release. Similar results have been obtained 
in the rat (Lodge, Headley, Duggan & Biscoe, 1974).
The investigations described here are an endeavour to 
elucidate further the interaction of opiate compounds with 
central acetylcholine receptors. The cholinoceptive Renshaw 
cell has been the site for this study and the effects observed 
with morphine-like compounds have been contrasted with those at 
non-cholinoceptive neurones of the spinal cord. It must at 
the outset be emphasized that Renshaw cells were employed in 
these investigations because of the well established cholinergic 
nature of the transmission at this synapse and that a role for 
this site in the mechanisms of morphine analgesia is unlikely.
In the initial studies experiments were performed on 
unparalysed pentobarbitone-anaesthetized animals.
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RESULTS
(i) STUDIES WITH CHOLINOCEPTIVE NEURONES
(a) Morphine Administered Electrophoretically
Morphine ejected electrophoretically was tested 
on 90 Renshaw cells. Three dose-dependent effects 
were observed: - excitation, antagonism of the 
depression of cell firing by glycine, and an increase 
in the latency of the initial action potentials of 
the synaptic response evoked by a submaximal ventral 
root stimulus.
Morphine excited 70 of these 90 Renshaw cells 
when ejected with currents of 25-80 nA. The excit­
ation was slower in onset than that produced by 
acetylcholine, but recovery was usually rapid on 
termination of the ejecting current. On the basis 
of ejecting currents required to produce equal 
increases in neuronal firing, the potency of morphine 
was the same order as that of L-glutamate and L- 
aspartate, but approximately one fifth to one tenth 
that of acetylcholine. Excitation of a Renshaw cell 
by morphine, L-aspartate and acetylcholine is illus­
trated in Figure 2.
The sensitivity of Renshaw cells to morphine was 
related to their sensitivity to acetylcholine, and 
the significance of this correlation is shown in 
Table II. With cells relatively insensitive to 
acetylcholine, the ejection of morphine with large
currents resulted in firing in bursts with little
R E N S H A W  CELLS
A
MORPH MORPH 
L-ASP 50nA
MORPH MORPH 40nA 
ACH 15n A
'mIFT'
B mm ACH lOnA
MORPHINE 15nA •“  OLH 25nA
c
MORPHINE 20n A 40nA
— ACH 20nA 
^  L-ASP 70nA
MIN'
F i g  ._____2: E x c i t a t i o n  o f  Renshaw c e l l s  by m o r p h i n e .  E a c h
t r a c e  i s  a r a t e m e t e r  r e c o r d  o f  c e l l  f i r i n g .  O r d i n a t e : 
s p i k e s  p e r  s e c o n d .  A b s c i s s a : t i m e  i n  m i n u t e s .  The t i m e s  
o f  e j e c t i o n  o f  s u b s t a n c e s  e l e c t r o p h o r e t i c a l l y  a r e  i n d i c a t e d  
by s y m b o l s  a b o v e  e a c h  t r a c i n g .  A. E x c i t a t i o n  by  m o r p h i n e  
(MORPH), a c e t y l c h o l i n e  (ACH) a n d  L - a s p a r t a t e  (L -A S P ) .  B. 
E n h a n c e m e n t  o f  e x c i t a t i o n  by a c e t y l c h o l i n e  b u t  n o t
D L - h o m o c y s t e a t e  (DLH) d u r i n g  e j e c t i o n  o f  m o r p h i n e .
C. E n h a n c e m e n t  o f  t h e  e x c i t a t o r y  a c t i o n s  o f  b o t h  
a c e t y l c h o l i n e  a n d  L - a s p a r t a t e  d u r i n g  e j e c t i o n  o f  m o r p h i n e .
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increase in mean firing rate.
Excitation by morphine was also manifested by 
an increase in the total number of action potentials 
evoked by a ventral root stimulus and enhancement 
of the actions of other excitants. In the rat, 
morphine has been reported to enhance the action of 
acetylcholine with little effect on that of other 
excitant amino acids (Lodge et. al. , 1974). This was 
observed on only 3 of 9 neurones in the present 
investigations (Fig. 2B), the more usual finding 
being enhancement of the action of all excitants 
tested (Fig. 2C).
The previously described actions of electro- 
phoretically administered morphine on ventral root 
evoked firing of Renshaw cells (Duggan & Curtis, 1972) 
were confirmed in the present experiments and are 
discussed below. Another effect previously reported, 
the reduction by morphine of the depressant action of 
glycine (Curtis & Duggan, 1969) was also confirmed, 
and several investigations were carried out to deter­
mine which of these effects of morphine occurred 
with the lowest ejecting current. There was no 
significant difference in the currents of morphine 
required to produce just detectable excitation and 
just detectable reduction of glycine depression.
(b ) Naloxone and Nalorphine Administered Electrophoretically
These compounds are n-allyl derivatives of the 
oxymorphone and morphine molecules which endows them 
with opiate antagonist properties. Their structures 
together with that of morphine and oxymorphone are
MORPHINE NALORPHINE
OXYMORPHONE NALOXONE
Fig.____ 3: The chemical structures of morphine, nalorphine,
oxymorphone and naloxone.
R E N S H A W  CELL
B
100
0L
100
ik CONTROL
ioor
li NALOXONE 30nA
0
100
g o
UJ£
£
NALOXONE 30nA MORPHINE 30nA
12 MSEC
F ig.____4_: The effects of naloxone and morphine on the
latencies of the initial action potentials of a Renshaw cell 
following a ventral root stimulus. Each histogram represents 
the sum of 128 responses analysed in 100 ysec intervals. 
Abscissae ; time in msec after the ventral root stimulus.
A. Controls. B. 2h minutes from the start of naloxone 
(30 nA) ejection. C. 5 minutes from the start of naloxone 
(30 nA) ejection and 1% minutes from the start of added 
ejection of morphine (30 nA). D. 4^ minutes from the 
cessation of ejection of morphine and naloxone. The 
reduction in action potential amplitude during ejection of 
naloxone and morphine reduced the total counts of the second 
and third action potentials as these were superimposed on a 
positive field potential.
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shown in Fig. 3.
These substances were tested both for effects 
on cell firing per se and for possible antagonism 
of the effects of morphine.
Naloxone ejected with currents of up to 30 nA 
had little effect on cell firing. Ejected with 
higher currents, up to 60 nA, and for times used to 
demonstrate excitation by morphine (up to 2 minutes), 
naloxone excited 2 of 19 Renshaw cells. Bursts of 
action potentials and a decrease in amplitude similar 
to those produced by high currents of morphine could 
be observed at these excessive currents. When 
ejected for longer periods, during tests for 
antagonism of morphine's effects, excitation by 
naloxone in the form of enhancement of either spon­
taneous firing or the action of an excitant amino 
acid, was observed with 9 of 19 neurones. The fir­
ing rate attained under these conditions was always 
less than fifty per cent of that produced by similar 
currents of morphine ejected for much shorter' times.
Naloxone (20-50 nA) was morphine-like in that it 
increased the latency of action potentials evoked by 
a submaximal ventral root stimulus on 6 neurones, the 
results from one being shown in Fig. 4. Also illus­
trated is that morphine, ejected subsequently to 
naloxone, further increased cell latencies, the 
effects of the two substances being additive rather 
than antagonistic. Tests in which morphine was 
ejected prior to naloxone failed to detect antagonism 
between these two compounds.
A
MORPHINE 15n A
NALOXONE 10n A
1 MIN
B _  GABA 12nA
MORPHINEl5nA 
NALOXONE 20nA
. .  GLYCINE 10nA
Fig.____ 5_: Failure of naloxone to antagonize the reduction
by morphine of glycine depression of the firing of a Renshaw 
cell. Spontaneous firing was depressed by the alternated 
ejection of glycine and y-aminobutyric acid (GABA.)
A. Naloxone ejection commenced after that of morphine.
B. On the same cell naloxone ejection commenced prior to 
that of morphine.
A
RENSHAW CELL
MORPHINE 27nA 
ACH 20nA
NALOXONE 20nA 25nA
4 M B  M l
MORPHINE 25nA 
DLH 20nANALOXONE 20nA
MIN '
Fig .___ 6: Antagonism by naloxone of excitation of a
Rensnaw cell by morphine and acetylcholine. A. Reduction 
of excitation by morphine and acetylcholine (ACH) during 
ejection of naloxone. B. Reduction of excitation by 
morphine with little effect on that of DL-homocysteate (DLH) 
during ejection of naloxone.
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Naloxone (10-60 nA) had no effect on the 
depression of cell firing by glycine and GABA and 
did not antagonize the reduction of the action of 
glycine by morphine on all seven cells tested.
This is illustrated in two ways in Figure 5.
When naloxone was ejected during the administration 
of morphine the depressant action of glycine, pre­
viously blocked, did not alter (Fig. 5A) whilst 
Figure 5B shows that on the same Renshaw cell, a 
concentration of naloxone without effect on the 
actions of glycine or GABA did not prevent the 
antagonism of glycine by subsequent morphine.
Higher currents of naloxone relative to morphine 
were difficult to test and these substances were 
additive in reducing action potential amplitudes.
Naloxone ejected with currents of 10-30 nA 
antagonized excitation by morphine and by acetyl­
choline but not that by an amino acid. This occurred 
with 15 of 18 Renshaw cells tested and results from 
one are shown in Figure 6. Concentrations of 
naloxone adequate to reduce the action of morphine 
were, on 9 occasions, weakly excitatory and Figure 6A 
also illustrates this.
An attempt was made to determine if naloxone 
was more potent as a morphine antagonist than as 
an acetylcholine antagonist. Two findings suggested 
that this was not so: - firstly a parallel reduction 
in the excitation produced by morphine and by acetyl­
choline, and secondly, when naloxone was tested 
against enhancement of the excitatory response to
RENSHAW CELLS
NALORPHINE 30nA
—  MORPHINE 70nA 
...L-GLUT 70nA
■  ■ ■ ■  ■ ■ ■ ■ ■
£
Q_
cO
LU
Q-
CO
B
NALORPHINE 15nA
...DLH 20nA 
_  ACH 23nA
MIN '
Fig. 7: Antagonism by nalorphine of excitation of a
Renshaw cell by morphine and acetylcholine. A. Reduction 
of excitation by morphine with little effect on that of 
L-glutamate (L-GLUT) during ejection of nalorphine. B. 
Reduction of excitation by acetylcholine (ACH) with little 
effect on that of DL-homocysteate (DLH) during ejection of 
nalorphine .
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acetylcholine and an amino acid by morphine, the 
action of acetylcholine was reduced more than that 
of the amino acid.
As discussed previously, a postsynaptic sensi­
tizing action by morphine of the response of the 
colon to acetylcholine has been proposed (Pollock et 
al. , 1972; Muir & Pollock, 1973). It is possible 
then that the reduction of the action of acetyl­
choline by naloxone was antagonism of the action of 
morphine on cells that had been sensitized to acetyl­
choline by the leakage of small amounts of morphine 
from micropipettes. Four experiments were therefore 
performed using micropipettes, none of the barrels of 
which contained morphine, but naloxone still reduced 
the action of acetylcholine on Renshaw cells.
Nalorphine was similar to naloxone in reducing 
excitation by morphine and by acetylcholine with little 
or no effect on that by an amino acid. This was 
observed on 5 of 7 neurones tested and results from 
one are illustrated in Figure 7. A weak excitatory 
action by nalorphine, similar to that produced by 
naloxone could be detected after prolonged admin­
istration. Nalorphine was not adequately tested for 
antagonism of the suppression by morphine of the 
inhibitory action of glycine, but was found to be 
morphine-like in prolonging, on the one neurone 
tested, the latency of action potentials evoked by 
a ventral root stimulus.
(c) The Pharmacology of Morphine Excitation
Renshaw cell cholinergic receptors have been
RENSHAW CELL
A
. .  DIH 15nA
NALOXONE 10n A -  ACH,5nA
'  „ AC-B-METH 30nA
B . .  DLH 30nA
NALOXONE 10nA _  ACH 15nA 
A NICOTINE InA
Fig .___ 8_: Effects of naloxone on excitation of a Renshaw
cell by acetylcholine, acetyl-B-methylcholine and nicotine. 
A. Reduction by naloxone of the excitant effect of 
acetylcholine (ACH) but not that of acety1-3-methylcholine 
(Ac-3-METH) and DL-homocysteate (DLH) on a Renshaw cell. 
Naloxone (10 nA) was ejected for a total of lh minutes not 
all of which is illustrated. B. Reduction by naloxone of 
excitation of a Renshaw cell by acetylcholine and nicotine 
but not that by DL-homocysteate. These records were 
obtained from the same cell as those of A. Naloxone (10 nA) 
was ejected for a total of 9h minutes not all of which is 
illustrated.
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shown by Curtis & Ryall (1966) to be of both nicotinic 
and muscarinic types. It was therefore of interest 
to determine in more detail the pharmacology of 
excitation by morphine as it became apparent that 
this activity was exerted at the same or similar 
receptors as those for acetylcholine. Experiments 
were carried out to ascertain the effects of naloxone 
on the excitation of Renshaw cells by nicotinic and 
muscarinic agonists (nicotine and acetyl-3-methyl- 
choline respectively), and of nicotinic and muscarinic 
antagonists (dihydro-3-erythroidine and atropine 
respectively) on excitation by morphine.
In these tests, naloxone consistently reduced 
the excitation by acetylcholine (15 cells) and 
nicotine (8 cells) but had no effect or enhanced that 
produced by acetyl-8-methylcholine (9 cells) and 
DLH (9 cells). The results obtained from one Renshaw 
cell are shown in Figure 8.
Dihydro-8-erythroidine (DH3E) ejected with small 
currents (4-10 nA), reduced in parallel the 
excitation of 4 of 5 neurones by acetylcholine 
and morphine. With one neurone, acetylcholine 
excitation was reduced while that of morphine was 
unaffected by DH8E. Atropine reduced morphine and 
acetylcholine responses in parallel on 4 neurones 
although relatively high currents of atropine 
(25-40 nA) were required and the effects were small 
compared with those of DHBE. Neither of these two 
antagonists affected the excitatory responses of 
amino acids. Figure 9 illustrates the actions of
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—  ACH 12nA 
. . .  DLH 18nA 
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Fig .____ 9: Effects of dihydro-ß-erythroidine and atropine
on excitation of a Renshaw cell by morphine, acetylcholine 
and DL-homocysteate. A. Reduction by dihydro-ß-erythroidine 
(DHßE) of the excitant effect of morphine and acetylcholine 
(ACH) but not that of DL-homocysteate (DLH) on a Renshaw 
cell. Not all the recovery period is illustrated the gap 
in record representing 6 minutes. B. Slight reduction of 
the effects of acetylcholine and of morphine but not that of 
DL-homocysteate during the ejection of atropine with relatively 
large currents. Atropine was ejected with a current of 10 nA 
for 3 minutes, 20 nA for 3 minutes, 30 nA for 3 minutes and 
40 nA for lh minutes. Not all of the responses during this 
total period of ejection are illustrated. The recovery 
responses were observed two minutes after the cessation of 
atropine ejection.
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DH3E and atropine on the responses of a Renshaw cell 
to morphine, acetylcholine and DLH.
(d) Intravenously Administered Morphine and Naloxone
Results concerning the effects of intravenous 
morphine and naloxone on the firing of Renshaw cells 
in response to a submaximal ventral root stimulus 
were obtained from 10 animals.
Morphine was administered in a series of 
gradually increasing doses as described in Chapter II. 
Whilst the hypotension and pulse pressure fluctuation 
were minimized by this measure (see Fig. 20), severe 
respiratory depression was still present with the 
doses employed as elevated levels of end tidal CC>2 
could be observed. Naloxone readily reversed both 
the respiratory and circulatory effects of morphine 
(see Fig. 20).
Peri-stimulus time histograms of ventral root 
responses of 8 Renshaw cells indicated that morphine 
in doses of 1-4 mg kg  ^enhanced the response in four 
experiments (2 with the spinal cord sectioned) and 
had no effect in four others.
The enhancement of ventral root firing following 
intravenous morphine was reversed by naloxone in all 
of three experiments and results from one are 
presented in Figure 10.
Naloxone given alone in doses of 0.1 - 0.5 
mg kg  ^had no significant effects on blood pressure 
or on the firing of Renshaw cells by ventral root 
volleys in 4 experiments. In a fifth animal such 
firing was depressed by about 25% following naloxone 
(0.3 mg kg ^).
A
R E N S H A W  CELL
NALOXONE 0.1 mg / kg
0 T6 I 1 I12 18 24 MSEC
Fig. 10: Enhancement of ventral root evoked firing of a
Renshaw cell by intravenous morphine and reversal of this 
effect by subsequent naloxone. Each histogram represents 
the sum of 123 responses analysed in 200 us intervals. 
Abscissa : time in ms after the ventral root stimulus.
Morphine was administered intravenously in three divided 
doses of 1 mg/kg at minute intervals, the middle record 
was computed 1 minute after the last dose of morphine. 
Naloxone 0.1 mg/kg was given intravenously 3 minutes after 
the last dose of morpnine and the lower record computed lh 
minutes subsequently.
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Higher doses of naloxone (2-3 mg kg were 
given to four pentobarbitone-anaesthetized spinal 
animals. These doses had no significant effects 
on blood pressure but in three animals limb move­
ments occurred. In three of these experiments, 
the total number of action potentials evoked by a 
sufcmaximal ventral root stimulus was decreased 
30-60% following intravenous naloxone. In a fourth, 
an increase of 50% was observed in the number of evoked 
action potentials, but "arousal" with naloxone was 
marked and spontaneous firing also increased by 
approximately 50%.
A specific effect of high doses of naloxone 
(2.7 mg/kg) on cholinergic synaptic activation of 
Renshaw cells from ventral roots, by comparison to 
activation from the dorsal roots,could be demonstrated 
in only 2 of 7 experiments. In 3 cases both types 
of activation were depressed, and in one other the 
dorsal root firing was increased with no effect on 
that of the ventral root. In the remaining experi­
ment naloxone was without effect on either type of 
activation.
(e) Studies with Morphinan Compounds
1. Administered Electrophoretically
As a further test of the specificity of the 
observed effects of morphine at nicotinic 
receptors on Renshaw cells, investigations 
were carried out using three morphinan compounds; 
levorphanol an active opiate analgesic (Fromherz, 
1951), dextrorphan an inactive isomer (Fromherz
LEVORPHANOL LEVALLORPHAN
DEXTRORPHAN
Fig. 11: The chemical structures of levorphanol,
levallorphan and dextrorphan.
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1951) and levallorphan an opiate antagonist 
(Fromherz & Pelmont, 1952). The structures 
of these compounds are shown in Figure 11.
Ejected from an 0.1 M solution, levorphanol 
(10-40 nA) excited 5 of 14 Renshaw cells.
Ejected from a 25 mM solution in 100 mM NaCl 
levorphanol (20-100 nA) excited 18 of 24 Renshaw 
cells. Cells fired by an ejecting current of 
acetylcholine of less than 10 nA were usually 
also fired by levorphanol, whereas with cells 
less sensitive to acetylcholine, high currents 
of levorphanol,like those of morphine, tended 
to produce bursts of action potentials of 
diminished amplitude with little increase in 
mean firing rate.
In an attempt to compare the potency of 
levorphanol with that of morphine both substances 
were administered (levorphanol in NaCl) with 
similar currents to 8 Renshaw cells. In these 
tests the currents of morphine and of levorphanol 
to produce equal increases in cell firing were 
not significantly different and, as only a pro­
portion of the ejecting current was carried by 
levorphanol ions, it is probable that levorphanol 
was more potent as an excitant than morphine. 
Figure 12A illustrates the responses of one cell 
to acetylcholine, morphine and levorphanol and 
the lack of excitation by dextrorphan (see below).
The excitation by levorphanol of 8 of 9 
Renshaw cells was reduced or abolished by
RENSHAW CELL
A
ACH 10 DEXTR 40
LOR 40 —  MORPH 40 nA
B _  LOR 30nANALOXONE 15nA . . .  DLH 30nA
■  ■ ■ aaa aaa
M IN1
Fig. 12: Excitation of a Renshaw cell by levorphanol and
antagonism of this effect by naloxone. A. The responses 
to the ejection of acetylcholine (ACH 10 nA), levorphanol 
(LOR 40 nA), dextrorphan (DEXTR 40 nA) and morphine (MORPH 
40 nA). B. Reduction of the excitation by levorphanol but 
not that by DL-homocysteate (DLH) during ejection of naloxone.
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currents of naloxone (10-40 nA) which had no 
effect on, or in two cases enhanced, the action 
of an amino acid excitant (Fig. 12B).
When ejected for prolonged periods, levor- 
phanol produced a long lasting reduction in 
acetylcholine sensitivity. This was first 
observed with cells not directly excited by 
levorphanol and on which possible effects of 
the alkaloid on excitatory responses to acetyl­
choline and an amino acid were being examined. 
Under these conditions, levorphanol reduced 
excitation by both acetylcholine and an amino 
acid and whereas the sensitivity to the amino 
acid recovered within one minute, that to acetyl­
choline in 9 cases took 4-11 minutes. This 
effect is illustrated in Figure 13A. This 
prolonged recovery time is demonstrated more 
directly in Figure 13B where cell firing in 
response to continuous ejection of acetylcholine 
is shown. With all neurones studied, there was 
a further decrease in the response to acetyl­
choline immediately following the cessation of 
levorphanol ejection, indicating that levor­
phanol was having a mixed excitant/depressant 
action at the acetylcholine receptor.
The action of dextrorphan (10-50 nA) was 
tested on 16 Renshaw cells. The firing, both 
spontaneous and chemically induced, of 8 neurones 
was depressed, that of 6 unaffected and with two, 
weak excitation was observed with the first
R E N S H A W  CELL
LEVORPHANOL
20 nA 40nA
.  ACH 15nA 
.. DLH 20nA
■ ■ ■  ■ ■ ■ ■  ■ ■  mmm
acO
£  a.
coUJ
^ 0L
B
LEVORPHANOL 
30n A
, 50r-
Fig. 13: Prolonged reduction in acetylcholine sensitivity
of Renshaw cells following ejection of levorphanol.
A. Effect of levorphanol, ejected with currents of 20 nA 
for mins, 30 nA for 3 min and 40 nA for 1 min on excitation 
of a Renshaw cell by alternate ejection of acetylcholine 
(ACH) and DL-homocysteate (DLH). The time between the second 
and third sections of this record was 9 minutes. B. Effect 
of levorphanol on the firing of a Renshaw cell by continuously 
ejected acetylcholine (10 nA).
RENSHAW CELL
■  ■
DEXTRORPHAN 20nA _  ACH 15nA 
■■ DLH 30nA
Fig. 14: Depression of cell firing by dextrorphan.
Depression during dextrorphan ejection of the excitation of 
a Renshaw cell by alternate ejection of acetylcholine (ACH) 
and DL-honiocysteate (DLH).
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ejection of this compound but not with subsequent 
tests. Excitation by acetylcholine and amino 
acids were equally reduced by dextrorphan and,
>
in contrast to results with levorphanol, both 
recovered at a similar rate. This effect is 
illustrated in Figure 14. The depressant 
effect of dextrorphan on Renshaw cells was 
often of slower onset and offset than that of 
the inhibitory amino acids GABA and glycine.
Levorphanol and dextrorphan were also 
tested for effects on the firing of Renshaw 
cells in response to a submaximal ventral root 
stimulus. Both substances increased the latency 
of the individual action potentials, and post­
stimulus histograms prepared from one experiment 
are illustrated in Figure 15. Also depicted 
are the differing effects of these substances 
on the total number of evoked action potentials, 
levorphanol increasing and dextrorphan having 
little effect on this parameter. Because the 
active and inactive isomers had a similar effect 
on this response,the antagonist levallorphan 
was not tested in this way.
Levallorphan was tested on 29 Renshaw cells 
with variable results. With 13, excitation by 
acetylcholine and an amino acid were equally 
reduced, but a preferential reduction of 
excitation by an amino acid occurred with 5 
neurones and that by acetylcholine with 4. 
Regardless of the type of result,prolonged
R E N S H A W  CELL
LEVORPHANOL 30nA
I I I I I
0 10 20 MSEC
Fig. 15: Effects of electrophoretically administered
levorphanol and dextrorphan on the responses of a Renshaw 
cell to a submaximal ventral root stimulus. Each histogram 
represents the sum of 128 responses, analysed in 200 us 
intervals. Ordinates: time in ms after the ventral root
stimulus. A. Control. B. \\ minutes after the start of 
levorphanol (30 nA) ejection. C. 2 minutes after the 
cessation of levorphanol ejection. D. 2 minutes after the 
start of dextrorphan (50 nA) ejection. E. 2 minutes after 
the cessation of levorphanol ejection.
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depression akin to that produced by levorphanol 
was not observed.
Excitation by morphine was also reduced 
by levallorphan on all 6 neurones tested, but 
not specifically as in 5 instances excitation 
by another substance (L-aspartate with 3 cells, 
acetylcholine with 2 cells) was also reduced. 
Reduction of excitation of a Renshaw cell by 
L-aspartate and morphine following levallorphan 
ejection is shown in Figure 16A.
The possible interaction between levorphanol 
and levallorphan was studied on 3 occasions. 
Currents of levallorphan having minimal effects 
on excitatory responses to L-aspartate and acetyl­
choline failed to antagonize their subsequent 
reduction by prolonged ejection of levorphanol 
on two cells. With the third, excitation by 
morphine and levorphanol but not that by DLH, 
was reversed by levallorphan (Fig. 16B).
2. Intravenous Administration
Six experiments were performed on the 
effects of intravenous levorphanol on the firing 
of Renshaw cells following a submaximal ventral 
root stimulus. Levorphanol was given in a 
series of divided doses, the total dose varying 
from 0.5 mg kg  ^ to 4.8 mg kg ^. These doses 
of levorphanol produced an increase in arterial 
pulse pressure and respiratory depression, but 
there was considerable variation in the magnitude 
of these effects between animals.
R E N S H A W  C E L L S
LEVALLORPHAN 10nA
□ LEVORPHANOL 80nA  
_  MORPHINE 80nA  
L-ASP 90nA  
DLH 5nA
LU
uo
QL
LU
lO
LU
XZ
% 0
B
LEVALLORPHAN 30nA
I -------T MIN
F i g .  1 6 : E f f e c t s  o f  l e v a l l o r p h a n  o n  e x c i t a t i o n  o f
R e n s h a w  c e l l s  by  m o r p h i n e ,  l e v o r p h a n o l ,  D L - h o m o c y s t e a t e  
arid L - a s p a r t a t e .  A. R e d u c t i o n  o f  e x c i t a t i o n  by  m o r p h i n e  
a n d  L - a s p a r t a t e  (L-ASP)  d u r i n g  e j e c t i o n  o f  l e v a l l o r p h a n  
(10 n A ) , f o r  6 h  m i n u t e s .  B. R e d u c t i o n  o f  t h e  e x c i t a t i o n  
by  m o r p h i n e  a n d  l e v o r p h a n o l  b u t  n o t  t h a t  by D L - h o m o c y s t e a t e  
(D-.Ii) d u r i n g  e j e c t i o n  o f  l e v a l l o r p h a n .  L e v a l l o r p h a n  w a s  
e j e c t e d  w i t h  c u r r e n t s  o f  10 nA f o r  3h m i n u t e s ,  20 nA f o r  
3 m i n u t e s  a n d  30 nA f o r  2 m i n u t e s  p r i o r  t o  t h e  m i d d l e  
r e c o r d s  b e i n g  o b t a i n e d .  L j e c t i o n  (30 nA) was  c o n t i n u e d  
f o r  1 m i n u t e  b e y o n d  t h e s e  r e c o r d s .  T h r e e  m i n u t e s  l a t e r  
t u e  r i g h t  h a n d  r e s p o n s e s  w e r e  r e c o r d e d .
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The evoked firing of 5 cells was unchanged 
by intravenous levorphanol, and the responses 
of the remaining cell slightly enhanced by a 
dose of 1 mg kg  ^but markedly depressed by 
a total dose of 4 mg kg ^.
Levallorphan (0.3 mg kg was given to 
one animal in which the responses of a Renshaw 
cell were unaffected by levorphanol and increased 
the synaptic firing above that of control 
observations. Levallorphan (0.2 mg kg , 
administered intravenously to one animal in 
which the synaptic responses of a Renshaw cell 
were enhanced by morphine (2 mg kg  ^I.V.), 
reduced responses to below those of controls.
Naloxone (0.1 mg kg was given to two 
animals following levorphanol. In one, both 
levorphanol and naloxone were without effect 
on the firing of a Renshaw cell, but in the other 
the depression of ventral root evoked firing of 
a Renshaw cell by levorphanol (4 mg kg was 
antagonized by naloxone.
Hence whilst the effects of narcotic agonists 
on Renshaw cell firing was variable, the anta­
gonists reversed an effect regardless of its 
type.
(f) Physostigmine
Investigations of the interaction of this sub­
stance with the action of morphine on Renshaw cells 
were prompted by the following findings: - 
1. The present results suggested that morphine
PHYSOSTIGMINE 10nA
-  ACHlnA  
M MORPHINE 60nA 
■■ DLH lOnA
Fig. 17: The effects of physostigmine on the responses of
a Renshaw cell to excitants. The ejection of physostigmine 
(10 nA) enhances the responses to acetylcholine (ACH) and 
morphine but not that to DL-homocysteate (DLH).
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exerted an excitatory effect by interaction with 
postsynaptic receptors for acetylcholine.
These findings however did not exclude an 
acetylcholine-releasing action by morphine as 
proposed by Lodge et al. (1974), and investi­
gations utilizing an anticholinesterase may be 
a way of distinguishing between these two 
mechanisms.
2. Physostigmine exhibits analgesic properties 
in tests such as the inhibition of rat tail flick 
(Bhargava & Way, 1972).
3. Sub-analgesic doses of physostigmine have 
been shown to cause previously inactive narcotic 
antagonists such as nalorphine, but not naloxone, 
to become agonists in rat tail flick tests 
(Harris, Dewey, Howes, Kennedy & Pars, 1969).
4. Physostigmine is one of the few non-opiate 
substances which competes with dihydromorphine 
for stereospecific central opiate binding sites 
(Klee & Streaty, 1974).
The effects of ejection of physostigmine 
on the responses of Renshaw cells to opiate 
agonists was tested on 9 occasions. For 
retaining purposes the physostigmine was made 
up in a NaCl solution and currents employed were 
low (1-19 nA) to minimize the postsynaptic 
excitatory actions reported to occur with this 
substance (Curtis & Ryall, 1966). The 
excitatory responses to acetylcholine were
potentiated by physostigmine on all 9 cells
A
PHYSOSTIGMINE 
3n A
«  ACH InA 
. .  DLH 15nA 
~  NALORPHINE 20nA
B
PHYSOSTIGMINE
3n A
— ACH InA 
■■ DLH 16nA 
-* NALOXONE 30nA
Fig. 18: The effects of physostigmine on the responses
of a Renshaw cell to opiate antagonists. A. Enhancement of 
the excitatory responses to acetylcholine (ACH) and 
nalorphine but not that to DL-homocysteate (DLH) during 
ejection of physostigmine (3 nA). B. Enhancement of the 
responses to acetylcholine (ACH) and naloxone (previously 
negligible effect) but not that of DL-homocysteate (DLH) 
during ejection of physostigmine (3 nA).
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tested and that of an opiate agonist on 8 
cells (morphine 4 of 5 cells, levorphanol 4 
cells). These enhanced responses occurred 
without affecting excitant amino acid 
responses on all occasions and, as shown 
in Figure 17, were readily reversible.
As previously reported, both the opiate 
antagonists naloxone and nalorphine are weak 
excitants of Renshaw cells although high firing 
rates are not attained by large ejecting 
currents. Physostigmine (1-5 nA) potentiated 
the weak excitatory actions both of naloxone 
(8 of 11 cells) and nalorphine (10 of 18 cells) 
in the absence of any effects on excitation by 
DLH, but in all cases that by acetylcholine 
was increased (Fig. 18).
In all of these tests with physostigmine on 
Renshaw cells, potentiation, both of acetylcholine 
and of the opiate agonists and antagonists, was 
observed as an increased firing rate during their 
time of ejection. No prolonged firing following 
the termination of the ejecting current was seen 
with the recording time constants used.
(g) Oxymorphone
This opiate agonist was tested for its ability 
to excite Renshaw cells. Since naloxone is the 
n-allyl derivative of oxymorphone (see Fig. 3), 
oxymorphone effects were expected to be more speci­
fically antagonized with naloxone.
The actions of oxymorphone (20-60 nA) were tested
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initially by observing its effects on the excitatory 
responses of 19 Renshaw cells to acetylcholine and 
an amino acid. On 10 occasions the responses 
to both excitants were enhanced, on seven those to the 
amino acid alone were enhanced and no effect on either 
was observed twice. Naloxone was also tested on both 
types of excitatory response on 10 of these 19 
neurones and acetylcholine responses were speci­
fically antagonized on 8 occasions.
It was common for oxymorphone to produce bursts 
of action potentials during both spontaneous and drug 
induced periods of cell firing (11 of 19 cells), 
particularly after prolonged periods or relatively 
high currents of administration. A weak excitatory 
action of oxymorphone also became apparent under 
such conditions. This effect resembled that already 
described for naloxone, the administration of which 
was additive to the slowly rising cell firing rate 
and not antagonistic. Oxymorphone directly excited 
two Renshaw cells but this effect was not antagonized 
by naloxone. The number of ventral root evoked 
action potentials was also increased by oxymorphone 
(20 nA) on two cells tested but subsequent naloxone 
(20 nA) failed to antagonize this effect.
(ii) STUDIES WITH NON-CHOLINOCEPTIVE NEURONES
I ~ UNIDENTIFIED OR CLASSIFIED BY PERIPHERAL FIBRE ACTIVATION 
To investigate whether the effects of morphine and the 
other opiate compounds described on Renshaw cells are 
peculiar to sites of cholinergic transmission, these com­
pounds were tested at spinal sites where transmission is
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believed to be other than cholinergic.
(a) Morphine and Naloxone Administered Electrophoretically
Morphine and naloxone were ejected electrophoretic­
ally in the vicinity of 55 dorsal horn interneurones from 
the same pipettes used in the studies on Renshaw cells.
Of 19 neurones tested with acetylcholine, 5 were weakly 
depressed and the remainder unaffected. The responses of 
these neurones to morphine and naloxone did not differ from 
the cells on which acetylcholine was not tested. Extensive 
studies on these neurones have shown them not to be excited 
by acetylcholine (Curtis, Ryall and Watkins, 1966). With 
23 of these neurones, the cutaneous fibre types activated 
by the minimum stimulus adequate for neurone activation was 
determined. Table III lists the reponses of these cells to 
electrophoretically administered morphine (5-100 nA) and 
naloxone (5-80 nA).
Neuronal firing, either spontaneous or chemically in­
duced was frequently depressed by morphine and naloxone 
although this depression was weak in comparison with that 
produced by glycine and GABA (see Fig. 21).
The ejecting currents of morphine and naloxone to produce 
equal depressant effects on cell firing did not significantly 
differ. Nalorphine also depressed the firing of 1 of 2 
cells tested.
Naloxone did not antagonize the depression of neuronal 
firing by morphine on any of the 12 cells tested. Similarly, 
the inhibitory actions of the amino acids GABA and gly­
cine were unaltered by naloxone on 15 occasions 
and these effects are illustrated in Figure 19.
SPINAL INTERNEURONE
A MORPHINE m o r ph in e  m o rphine n a l o x o n e
i
oL
2 mgkg 1
7 m i n
l
I 2 M IN
p
l
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l
Fig. 20: The effects of morphine on blood pressure and
the spontaneous and synaptic firing of a non-cholinoceptive 
spinal interneurone and the reversal of these effects by 
naloxone. Three intravenous injections of morphine and one 
of naloxone were given in doses and at times marked by the 
arrows. A. Spontaneous cell firing obtained prior to 
injection of morphine and approximately 1 minute after the 
first and third injections of morphine and the injection of 
naloxone. B. Post stimulus histograms computed at 
corresponding times. Cell firing following a stimulus to 
the ipsilateral sural nerve 2.0 ms before the commencement 
of each illustrated record was analysed in 200 ys intervals; 
128 such responses were summed to produce each histogram.
C. Blood pressure measured in a carotid artery at the times 
of injection of drugs.
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The depressant action of glycine is blocked by 
morphine on both Renshaw cells and interneurones 
(Curtis & Duggan, 1969), but as with Renshaw cell 
studies, this effect of morphine was not antagonized 
by naloxone on six interneurones.
The possible effects of electrophoretically 
administered morphine on synaptic activation of 
five spinal interneurones were studied by compiling 
peri-stimulus time histograms in response to 
stimulation of a branch of the ipsilateral sciatic 
nerve. No effect was observed on three of these 
neurones, the responses of one were depressed and 
morphine (50 nA) enhanced the synaptic response of 
the remaining neurone which was also observed to be 
excited by acetylcholine.
(b) Intravenous Morphine and Naloxone
In three experiments the effects of intravenous 
morphine were studied on the synaptic activation of 
interneurones. Morphine in total doses of 7 mg kg  ^
reduced the responses of a dorsal horn interneurone 
to stimulation of a branch of the ipsilateral sciatic 
nerve in two experiments and had no effect on the 
third. Naloxone, 0.1 mg kg  ^reversed this 
depression of evoked firing by morphine and increased
spontaneous firing well above that of the control
\
observations in all three experiments. Results from 
one experiment are shown in Figure 20. Whereas the 
spontaneous firing (Fig. 20A) of this neurone was 
progressively depressed by increasing doses of 
morphine, firing in response to stimulation of the
SPINAL INTERNEURONE
M O R P H LOR D E X T G L Y C IN E
6 0 6 0 2 0 n A
Fig. 21: Depression of the spontaneous firing of a
non-cholinoceptive interneurone by ejection of levorphanol 
(LOxl) / dextrorphan (DEXT) and glycine. Lack of effect by 
morphine (MORPH) is also shown.
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ipsilateral sural nerve (Fig. 20B) was enhanced by 
morphine 1 mg kg  ^but depressed by higher doses.
Also illustrated is that after naloxone (0.1 mg kg 
the evoked firing returned approximately to control 
levels, but spontaneous firing rose to three times 
that present before injection of morphine.
In one experiment naloxone was injected intra­
venously in increasing doses from 0.1-0.4 mg kg ^.
No effect was seen on the synaptic or spontaneous 
firing of the interneurone studied. A subsequent 
dose of morphine (4 mg kg also failed to affect 
cell firing.
(c) Morphinans Administered Electrophoretically
Levorphanol (10-80 nA) did not excite dorsal horn 
neurones identified by stimulation of Aa fibres of 
branches of the sciatic nerve and their insensitivity 
to acetylcholine. Of 12 cells tested, levorphanol 
weakly depressed the spontaneous or chemically 
induced firing of 6. Depression by levorphanol 
(Fig. 21) was of moderately rapid onset and offset 
and often difficult to distinguish from that due to 
ejection of sodium ions.
Dextrorphan (10-40 nA) was a more consistent 
and potent depressant of these cells than either 
morphine or levorphanol (Fig. 21), the firing of all 
16 cells tested being depressed. Such depression 
was of slower onset and offset than that by GABA and 
glycine (Fig. 21).
(d) Physostigmine
Physostigmine was also tested on cells activated
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by low threshold dorsal root afferents in an attempt 
to distinguish differences in its action relative to 
effects at Renshaw cells. On seven occasions, a 
current of 2-10 nA had no effect on the depressant 
activity produced by morphine, naloxone or acetyl­
choline. As reported previously the depression by 
morphine was not antagonized by naloxone and this 
result was not altered by ejection of physostigmine 
on the one occasion tested. At the currents used, 
physostigmine was observed to have little effect 
per se on cell firing rate.
(e) Qxymorphone
Oxymorphone (29-80 nA) was administered in the 
vicinity of 14 dorsal horn interneurones, having no 
effect on 9, and weakly depressing the spontaneous 
firing of the remaining 5 neurones. This effect was 
not antagonized by naloxone on all occasions tested.
The results reported up to this point have been 
summarized in Table IV.
(iii) STUDIES WITH NON-CHOLINOCEPTIVE NEURONES
II ~ CLASSIFIED BY RESPONSE TO NOXIOUS AND NON-NOXIOUS 
ACTIVATION
It has been reported that morphine,administered 
electrophoretically in the vicinity of dorsal horn inter­
neurones of cats anaesthetized with a-chloralose, depressed 
the firing of neurones activated by noxious stimuli but 
was without effect on cells unresponsive to this type of 
stimulus (Calvillo, Henry & Neumann, 1974) and that 
naloxone, similarly administered, antagonized this effect 
on 2 of 7 neurones. As reported in the preceding section
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of this thesis, morphine administered electrophoretically 
depressed the firing of about one half of the dorsal horn 
neurones sampled, but in no case did similarly administered 
naloxone reverse this effect. As these neurones were not 
identified by responses to natural stimulation, a further 
series of investigations was carried out in decerebrate or 
a - chloralose anaesthetized animals. Cell positions 
marked with dye enabled dorsal horn neurones to be classi­
fied by laminar location (Rexed, 1954) in addition to 
responses to noxious and non-noxious stimulation which were 
produced by the methods already described.
(a) Distribution of Neurones and Responses to Natural 
Stimulation
The responses of neurones in the various layers 
of Rexed (Rexed, 1954) to noxious and non-noxious 
stimulation are summarized in Table V. This Table 
does not give a complete description of cell responses. 
Cells which were excited by a stimulus in one area but 
inhibited by a similar stimulus to another area of 
skin have been classified by their excitatory response. 
Cells in which an early excitation was followed by 
inhibition have also been classified by their 
excitatory response. Receptive field sizes differed 
considerably. Because of the complexity of responses 
the terms 'nociceptive' and 'non-nociceptive' have not 
been used. The Table does emphasize the rarity with 
which a cell responding to only one sensory modality 
was encountered.
(b) Responses to Electrophoretically Administered Morphine
1. Spontaneous Firing
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Table VI summarizes the effects of morphine 
on neurones classified by response to natural 
stimulation. It can be seen that morphine was 
relatively ineffectual as a depressant of cell 
firing, excitation being seen more commonly, and 
that there was no correlation between response to 
skin stimulation and the effects of morphine. 
Results from one neurone are shown in Figure 22.
Since intravenous morphine has been reported 
to depress selectively the spontaneous activity 
of neurones of Laminae I and V and to have little 
effect on that of neurones of other laminae 
(Kitahata et a_l. , 1974), Table VII summarizes the 
responses to electrophoretically administered 
morphine of cells in layers I to VII. Depression 
was observed only with cells of the deeper layers.
During these tests, the ejecting current of 
morphine was increased in a stepwise manner till 
abnormalities in action potential amplitude and 
configuration appeared. This occurred with 
currents of the order of 60 to 80 nA. Excitation 
by morphine took the form of firing in grouped 
action potentials (bursts) and was much weaker 
than that previously observed with Renshaw cells.
2. Excitation by L-Glutamate.
The effects of morphine on excitation by 
L-glutamate were variable. Of 13 neurones 
excited both by noxious and non-noxious 
stimulation of the skin, morphine (30-60 nA) 
enhanced the responses to glutamate on 5 and
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this was accompanied by an elevation in spon­
taneous firing and a further increase in 
excitation by L-glutamate immediately after 
morphine ejection. Depression of glutamate 
excitation occurred with 7 neurones but this 
was associated with abnormalities in action 
potential amplitude and configuration.
Excitation by "Natural" Skin Stimulation
Morphine, ejected with currents of 25-70 nA, 
reduced firing produced by noxious heat to the 
appropriate part of the hind limb on only 2 of 
37 cells tested. With 9 cells the response was 
enhanced together with an increase in spontaneous 
firing. To test for possible specificity in 
the effects of morphine, 6 cells were activated 
alternately by noxious heat and by a moving air 
jet directed at hairs adjacent to a digital pad. 
In no case was the response to either modality 
significantly reduced during morphine ejection, 
this result being illustrated in Figure 22A.
This figure illustrates the results from 1 of 
3 neurones, the responses of which to both 
noxious and non-noxious activation were 
enhanced by morphine at doses great enough to 
produce irregular firing in bursts.
As a further safeguard that these essentially 
negative results were not due to a failure to eject 
an adequate amount of morphine, on five cells 
depression of firing by glycine was alternated 
with excitation by noxious heat, as morphine is
A NOXIOUS HEAT 
HAIR DEFLECTIONMORPHINE 60nA
SO-.
0 J
—  NOXIOUS HEAT 
. .  GLYCINE 20nA
MIN
1
Fig. 22: The effect of morphine when administered near
the soma of a dorsal horn neurone. A. The responses to 
noxious heat applied to the fourth digital pad of the left 
hind limb, are enhanced to a greater extent than those to 
deflection of adjacent hairs by the ejection of morphine 
for a total of 7 minutes. That these effects were readily 
reversible is also illustrated. B. The effects of ejection 
of morphine are sufficient to block the depression caused 
by glycine but have negligible effect on the response to 
noxious heat. Morphine was ejected for a total of 5-;. 
minutes.
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known to block the action of glycine (Curtis 
& Duggan, 1969). In all cases currents of 
morphine more than twice those adequate to 
block the action of glycine had no significant 
effect on activation by noxious heat (Fig. 22B).
(c) Effects of Electrophoretically Administered Naloxone 
Ejected with currents of 20-60 nA, naloxone had 
no effect on the spontaneous firing of 10 cells and 
weakly depressed that of one. All these cells were 
activated both by noxious and non-noxious stimuli.
Naloxone reduced excitation by L-glutamate on 
4 of 7 neurones, but, following the period of ejection, 
responses to L-glutamate were enhanced by up to 100% 
of control values for periods of up to 10 minutes.
This effect of naloxone could be a cause of apparent 
antagonism of the effect of morphine when the latter 
also reduced excitation by L-glutamate. Thus in 
tests in which the responses to L-glutamate had been 
depressed by morphine, the simultaneous ejection of 
naloxone either had no effect or produced further 
depression, but the removal of naloxone,whilst 
morphine was still being ejected, resulted in 
responses greater than those prior to naloxone 
ejection.
Naloxone, ejected alone, did not modify the 
firing of cells by noxious heat.
Electrophoretically administered naloxone did 
not antagonize the effect of similarly applied mor­
phine in any of the tests, namely depression of 
excitation of L-glutamate (3 cells), enhanced
excitation by L-glutamate (3 cells), reduced 
excitation by noxious heat (1 cell), enhanced 
noxious heat (3 cells).excitation by
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DISCUSSION
The results of the initial two studies indicate that electro- 
phoretically administered morphine excited neurones by acti­
vating nicotinic receptors for acetylcholine. The evidence 
supporting this conclusion was provided by the following:
1. Distribution of nicotinic receptors. Nicotinic 
receptors are present on Renshaw cells (Curtis & Eccles,
1958; Curtis & Ryall, 1966) but not on other spinal inter­
neurones (Curtis, Ryall & Watkins, 1966). Investigations . 
carried out in this laboratory have demonstrated that 
ventrobasal thalamic neurones, which also possess 
nicotinic receptors (Andersen & Curtis, 1964) are 
excited by morphine, whereas neurones of the cerebral 
cortex possessing receptors with muscarinic properties 
Krnjevic & Phillis, 1963a; Crawford & Curtis, 1966)
were not excited by morphine. The distribution of 
nicotinic receptors therefore parallels that of excit­
ation by morphine and this series of results have been 
published collectively (Duggan, Davies & Hall, 1976).
2. Naloxone antagonized excitation by acetylcholine and 
nicotine but not that by acetyl-3-methylcholine.
3. Excitation of Renshaw cells by morphine was readily 
antagonized by DH3E.
The excitatory action of morphine at this site could
result from any of the following possible mechanisms:
1. An enhancement of the action of tonically released 
acetylcholine either through an inhibition of cholin­
esterase or sensitization of postsynaptic receptors.
2. A release of acetylcholine from presynaptic terminals.
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3. Activation of postsynaptic receptors for
acetylcholine.
Inhibition of cholinesterase can probably be excluded 
as a possible explanation by the finding that nalorphine, 
which did not excite Renshaw cells, is as potent as morphine 
as an inhibitor of rat brain cholinesterase (Dewey, Harris,
Howes, Kennedy, Nuite & Hayhurst, 1969). In addition, no 
detectable prolongation of the action of acetylcholine or any 
other excitant was observed during morphine ejection, and the 
action of an excitant amino acid was usually enhanced to a 
similar extent as that of acetylcholine. Several studies have 
indicated a lack of correlation between inhibition of cholin­
esterase and narcotic analgesic potency (Young, Van der Ploeg, 
Featherstone & Gross, 1955; Dewey et al♦, 1969; Szerb, 1957).
A release of acetylcholine from presynaptic terminals 
by morphine administered electrophoretically has been proposed 
by Lodge e_t al. (1974) after their observation that morphine 
enhanced the action of acetylcholine more than that of DLH on 
Renshaw cells of the rat. Morphine also increased the latency 
of the ventral root evoked action potentials and these authors 
proposed that some of these effects of morphine could be 
explained if it caused a partial depolarization of both the 
Renshaw cell and the presynaptic terminal. This latter effect, 
which has been proposed as a mechanism of presynaptic inhibition 
(Eccles, 1964; Schmidt, 1971), could account for the increased 
latency of the ventral root response whereas the increase in 
the number of action potentials could be due to an increase in 
the postsynaptic membrane excitability, and thus the sensitivity 
to acetylcholine, by morphine. A presynaptic depolarizing 
effect would increase spontaneous release of transmitter (Del
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Castillo & Katz, 1954; Liley, 1956) and this might possibly 
account for the elevation in Renshaw cell excitability which 
was observed. Indeed, such a mechanism of action of morphine 
cannot be completely ruled out from the findings reported here.
To pursue the question of the mechanism of action of morphine, 
the experiments with physostigmine were performed. These 
results,which are discussed below, provide no decisive 
information concerning this problem.
In the present investigations, the reduction of the effects 
of electrophoretically administered acetylcholine and nicotine 
by naloxone is almost certainly a postsynaptic effect at 
receptors for acetylcholine. The simplest explanation for a 
parallel reduction by opiate and cholinergic antagonists of 
the excitation by morphine and acetylcholine is that morphine 
is also acting postsynaptically. If, however, morphine 
releases presynaptically stored acetylcholine and naloxone 
antagonizes this action, then excitation by morphine should 
be more readily reduced by naloxone than excitation by acetyl­
choline. This was not observed.
The results with levorphanol are consistent with an 
excitatory effect at nicotinic receptors, an action not observed 
with dextrorphan. The prolonged decrease in acetylcholine 
sensitivity also observed with levorphanol, however, is similar 
to the effect of atropine ejected electrophoretically (Krnjevic 
& Phillis, 1963b). Whilst levallorphan showed naloxone-like 
activity on a few Renshaw cells, in most cases this narcotic 
antagonist non-specifically reduced the activity of all excitants 
tested. In microelectrophoresis studies, such activity is also 
shown by procaine (Curtis & Phillis, 1960). These results with 
morphinans,therefore, showed similarities to those obtained with
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morphine and naloxone but also significant differences.
Activity shown by morphinans in other experiments may be 
relevant to these differences. Both levorphanol and levall- 
orphan are toxic to cell cultures and inhibit RNA synthesis 
(Simon, 1971), and all three of the morphinan compounds tested 
in the present investigations are more potent than morphine as 
local anaesthetics at the squid axon (Simon & Rosenberg, 1970). 
Dingledine & Goldstein (1973) have also shown that prior naloxone 
administration to mice reduces the lethality of LD^g doses of 
levorphanol, but that it is ineffective at higher doses of 
levorphanol and of dextrorphan. In addition, levorphanol is 
approximately one thousand-fold more lipid-soluble than morphine 
(Von Cube et a_l. , 1970) , a property which may limit its distri­
bution when ejected from a micropipette. This characteristic 
may result in relatively high concentrations in the vicinity 
of the tip of the micropipette and could explain both the 
inability to attain high firing rates with levorphanol and the 
predominantly local anaesthetic type of activity exhibited by 
levallorphan.
Morphine also has an excitatory effect on neurones of the 
rat brainstem (Bradley & Dray, 1974), and whereas no correlation 
between excitation by morphine and by acetylcholine was found, 
a subsequent report from that laboratory (Bramwell & Bradley, 
1974) suggests that such a correlation exists. Nicotinic 
receptors for acetylcholine can be readily demonstrated in the 
brainstem of the decerebrate rat (Duggan, Headley & Lodge, 1975), 
but not in the cat (Duggan & Game, 1975). Bramwell & Bradley, 
(1974) reported that naloxone did not block the excitation of 
brainstem neurones of the rat by morphine but blocked the 
depression which followed excitation, but the specificity of
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this effect in the absence of control responses to other 
depressants cannot be evaluated. The response to morphine was 
tested after, but not during, the ejection of naloxone and this 
may explain the failure to observe antagonism of morphine's 
excitation, since in the results presented here, naloxone's 
effects were rapidly reversible.
Other studies of the effects of morphine administered 
electrophoretically show differences from the present results.
A depression by morphine of the activity of spinal interneurones 
of Laminae IV, V and VII of the cat has been reported (Dostrovsky 
& Pomeranz, 1973). These authors interpret this effect, which 
was observed as a reduction of the excitatory responses to 
L-glutamate, as a blockade of postsynaptic L-glutamate receptors, 
but since this is not observed with Renshaw cells, it may be 
that morphine depresses cell firing by another mechanism. 
Furthermore, the failure of naloxone to antagonize this effect 
casts doubt on its relevance to the actions of systemic morphine. 
Intracellular recording from feline spinal neurones has also 
demonstrated that morphine blocks the depolarization due to 
L-glutamate (Zieglgansberger, Satoh & Bayerl, 1975). These 
authors found that morphine depressed 60% of the cortical 
neurones studied in the rat and could also antagonize the 
excitatory effects of L-glutamate and acetylcholine on these 
neurones. Both of these effects, in the cat and in the rat, 
could be reversed by naloxone, also administered electro­
phoretically .
The studies reported here with physostigmine suggest that, 
if it acted purely as an anticholinesterase, then morphine and 
levorphanol excite neurones by release of acetylcholine, and that 
naloxone and nalorphine also have this action. Enhancement of
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the action of acetylcholine seen at the same time however, would 
suggest that this is not so. An interaction between anti­
cholinesterases and nicotinic receptors of Renshaw cells has 
been proposed (Curtis & Ryall, 1966) to account for the lack 
of correlation between enhancement and prolongation of the 
action of acetylcholine, the depression by edrophonium of 
acetylcholine sensitivity and the block by DHßE of excitation 
produced by these substances.
The ability of physostigmine to affect the responses of 
Renshaw cells to opiate compounds but not those of noncholino- 
ceptive neurones might be taken to suggest a similarity between 
the receptor for acetylcholine and the opiate receptor studied 
in the binding experiments (Terenius, 1973), but other effects 
not always related to cholinoceptive neurones have been reported 
for this substance. Physostigmine has been reported to have 
predominantly excitatory effects on a proportion of brainstem 
neurones of the cat which could not be correlated with responses 
to acetylcholine (Salmoiraghi & Steiner, 1963; Bradley, Dhawan 
& Wolstencroft, 1966). Although relatively high concentrations 
were required to produce these effects, the responses of brain­
stem neurones to acetylcholine were shortened in latency and 
prolonged in offset in the presence of physostigmine.
Spehlmann (1963) has also reported that cortical neurones were 
excited by electrophoretically administered physostigmine alone 
as well as this substance enhancing the effect of acetylcholine.
The report by Harris et a^., (1969) that nalorphine but
not naloxone exerts agonist activity in the presence of low 
concentrations of physostigmine in tail flick tests does not 
correlate with the results of the present type of experiment.
The weak excitatory effects of both naloxone and nalorphine were
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enhanced by physostigmine. It may be that this effect of 
physostigmine is unrelated to anticholinesterase properties 
in which case it would be not amenable to testing by the 
methods employed here.
Physostigmine enhances the inhibition of trigeminal 
motoneurones by impulses in cutaneous nerves (Iwata, Sakai 
& Deguchi, 1971) and such an action may be relevant to the 
activity of this substance in procedures which purport to 
test for analgesic activity.
The studies with oxymorphone and Renshaw cells indicate 
that it has several properties similar to morphine, namely 
the ability to potentiate the actions of other excitants and 
to be excitant, albeit weakly, itself. A major difference 
however, was the failure of naloxone to antagonize the effects 
of oxymorphone as well as the pronounced ability of this sub­
stance to produce bursts of action potentials. Hence, while 
oxymorphone and naloxone did exert different effects at the 
Renshaw cell receptor, they did not behave as agonist and 
antagonist compounds, a result which argues against the rele­
vance of these effects to those of systemic opiates.
The relevance of the investigations described here to the 
central effects of systemically administered opiates is 
rendered difficult by a lack of knowledge of concentrations 
obtained by electrophoretic administration. Four effects of 
morphine were consistently observed when administered electro- 
phoretically on spinal cord neurones -
1. An enhancement of the number of action potentials 
evoked by a ventral root stimulus, as well as a decrease in 
the latency of the second and subsequent action potentials.
2. Antagonism of the depression exhibited by glycine.
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3. Depression of dorsal horn interneurones.
4. Excitation of Renshaw cells and enhancement of
excitants.
Of these effects only the latter, excitation of Renshaw 
cells as a result of interaction with postsynaptic acetyl­
choline receptors, could be antagonized by similarly administered 
naloxone. If activity at nicotinic receptors therefore, is of 
importance to the central effects of systemically administered 
opiates, then drugs possessing activity at such receptors could 
be expected to influence these effects. A recent report by 
Phan et. a_l. (1973) has demonstrated the antinociceptive pro­
perties of nicotine. As presented in the introduction, however, 
the literature concerning the effects of cholinergic substances 
on analgesia,tolerance and withdrawal is controversial, as is 
that concerning morphine and the levels and release of 
acetylcholine.
The lack of activity of naloxone when administered 
systemically (Blumberg et al., 1961) would seem to be evidence 
of a major fault in the proposal that the activity of opiate 
compounds is a result of interaction with the postsynaptic 
receptors for acetylcholine. It must be recalled however, 
that with the exception of Renshaw cells, a role for central 
nicotinic receptors in synaptic transmission has not been con­
vincingly demonstrated (but see McCance, Phillis & Westerman, 
1968). Goldstein (1974) has proposed that if narcotic agonists 
and antagonists occupy the same receptor site, then the lack of 
central effects by naloxone implies that morphine cannot act by 
interfering with the action of a normally active transmitter.
If such receptors are located at sites other than functional 
synapses, then the acetylcholine-antagonist property of naloxone
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demonstrated here is consistent with the relative lack of 
central effects when this substance is given alone.
Consistent with Goldstein's hypothesis is the recent 
demonstration of a series of pentapeptides ("endorphins") 
extractable from brain tissue (Hughes, 1975; Terenius & 
Wahlstrom, 1975), possessing analgesic properties (Biischer 
et al., 1976) and able to displace opiates in binding experi­
ments (Hughes et a_l. , 1975). These peptides, the active parts 
of which have been suggested to correspond with active groups 
on the morphine molecule (Biischer et al. , 1976), may be 
released under particular conditions, e.g. stress to the 
organism, and if so, activity at receptors identical to those 
where opiates interact but distinct from those at normal 
functional synapses, could be reasonably invoked.
The results presented in the later study do not confirm 
the finding of Calvillo, Henry & Neumann (1974) that morphine 
administered electrophoretically to dorsal horn neurones 
depresses only those activated by painful stimulation. These 
authors reported a higher proportion of neurones not activated 
by painful stimulation, about 50% of their total number of 
neurones, than the present and other studies (Handwerker,
Iggo & Zimmerman, 1975; Price & Browe, 1973, 1975). Such a 
difference however, cannot explain the difference in results.
The findings presented in the second study of this 
section reported a high proportion of the neurones studied 
to be depressed by morphine and this was probably due to the 
sampling of neurones of deeper layers of the dorsal horn.
Deeper situated neurones of the present studies were more 
commonly depressed by morphine (Table VII).
The essentially negative results of the latter investigations
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cannot be explained by failure to eject an adequate amount of 
morphine. Currents used were in excess of those necessary to 
block the action of glycine (Curtis & Duggan, 1969;Dostrovsky
& Pomeranz, 1973) and were increased until abnormalities inaction 
potential amplitude and configuration appeared. An elemental 
analysis (performed by Microanalytical Service of this University), 
and the effects on blood pressure after intravenous admin­
istration and their reversal by naloxone, indicated the ade­
quacy of the purity and potency of the sample of morphine used.
Kitahata et al. (1974) have reported that intravenous mor­
phine 0.5-2.0 mg kg 1 depressed the spontaneous activity of 
neurones of Rexed Laminae I and V and not those of neurones in 
Laminae IV and VI. It has been reported (Christenson & Perl, 
1970; Hillman & Wall, 1969) that neurones in Laminae I and V 
respond principally to noxious stimuli while those in Laminae 
IV and VI are responsive to non-noxious stimuli. Results from 
the present and other studies (Handwerker et a_l. 1975; Price & 
Browe, 1975) suggest that this is an oversimplified concept as 
in the present experiments there was no correlation between 
the effects of morphine and laminar location except perhaps 
for the deep Laminae VI and VII. It becomes obvious that 
care must be taken when interpreting the effects of an intra­
venously administered drug at the single cell level.
While the present results do not lend support to the body 
of evidence implicating a spinal site of action, it must be borne 
in mind that the electrophoretic technique, which administers 
drugs to the extracellular environment of the neuronal soma, may 
be unable to duplicate the conditions consequent upon intravenous 
administration. Hence the inability to demonstrate depression 
by electrophoretically administered morphine of nociceptive
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responses of dorsal horn neurones cannot definitely provide 
support for or against a spinal site of action for morphine.
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B. EFFECTS OF MORPHINE AND NALOXONE ADMINISTERED INTO 
DENDRITIC REGIONS OF DORSAL HORN NEURONES
Introduction
The findings of the previous section indicated that mor­
phine, administered near cell bodies of dorsal horn neurones, 
did not produce effects which could be related to those of 
systemic morphine on responses to noxious or non-noxious 
stimulation. This result has two explanations - either the 
morphine-like compounds do not act in the dorsal horn or 
they were not administered to the appropriate site.
Since in the spinal cat, intravenous morphine reduces 
the activation of dorsal horn neurones by nociceptive 
afferents (Le Bars,Menetrey, Conseiller & Besson, 1975), the 
latter explanation, failure to administer the opiate to the 
appropriate site, was considered the more likely.
That receptors on dendrites might be relevant to the action 
of putative transmitter substances and possibly of drugs has 
been suggested by several studies (Diamond, 1968; Dudar, 1974; 
Ransom & Nelson, 1975; Yamamoto, 1976). It seemed possible 
then, that receptors distant from the cell body and related to 
the interactions of opiates might conceivably be present on 
Laminae IV and V neurones. It is these neurones which receive 
a large proportion of cutaneous and nociceptive afferents 
(Schimert, 1939; Wagman & Price, 1969; Handwerker, Iggo & 
Zimmerman, 1975; Price & Browe, 1975) and their dendritic pro­
cesses project dorsally to the substantia gelatinosa region of 
the dorsal horn (Laminae II and III; Cajal, 1909; Szentagothai, 1964) .
The substantia gelatinosa is a region cytoarchitectur- 
ally distinct from the rest of the dorsal horn and contains an
TRACT OF 
LISSAUER
SUBSTANTIA
GELATINOSA
Fig. 23: A diagramatic representation of the arrangement
of the two electrodes in the spinal cord. The vertical 
electrode which was positioned in the substantia gelatinosa 
region of the spinal cord was used for administration of 
compounds. The other electrode penetrated the spinal cord 
at an angle and located neurones in laminae IV or V which 
were appropriate for extracellular recordings (see Chapter 
II). The dendritic relationship between lamina IV and 
substantia gelatinosa neurones and with primary afferent 
terminals is also depicted diagramatically.
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✓  /abundance of axo-axonic synapses (Szentagothai, 1964; Rethelyi 
& Szentagothai, 1965; Scheibel & Scheibel, 1968; Mannen & 
Sugiura, 1976). It is this property of the substantia 
gelatinosa which has led Szentagothai (1964) to suggest that it 
may be involved in the "modulation of impulse transmission 
through the larger neurones of the dorsal horn". Melzack &
Wall (1965) have proposed that the substantia gelatinosa serves 
as a "gate control system" which modulates afferent nociceptive 
information. The proposal by these workers that the axo-axonic 
synapses of the substantia gelatinosa might be the basis of a 
mechanism of presynaptic inhibition of nociceptive primary 
afferents has not been demonstrated definitively from anatomical 
studies (Rethelyi & Szentagothai, 1965; Szentagothai, 1968; but 
see Rethelyi & Szentagothai, 1969).
The present investigation was an endeavour to influence 
the responses of Laminae IV and V neurones to noxious and non- 
noxious stimuli by the electrophoretic ejection of morphine, 
naloxone and other compounds in the region of substantia 
gelatinosa using the "two-electrode" technique outlined in 
Methods (Chapter 2, see Fig. 23). All animals were anaes­
thetized with chloralose and were artificially respired.
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Fig. 24: Depression by morphine of nociceptive but not
mechanoreceptor activation of a dorsal horn neurone and 
reversal of this effect by intravenous naloxone. The 
neurone was located in spinal lamina V and was activated 
by noxious heat to the third digital pad of the left hind 
limb and deflection of adjacent hairs: separation between 
tips of drug administering and recording micropipettes 
340 pm. The lower traces are pen recordings of cell firing 
in response to noxious heat and hair deflection and the 
upper record is a graph of response amplitude with respect 
to time of each stimulus. Spontaneous firing is also 
plotted. The bars above the graph indicate the times of 
ejection of morphine. The letters A , B , C and D indicate 
the times at which the lower tracings were recorded.
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RESULTS
(a) Effects of Morphine on the Responses of Lamina IV and V 
Neurones to Noxious and Non-noxious Stimulation
Morphine, ejected in the region of the substantia gelatinosa 
with currents of 30 to 250 nA, reduced the responses to noxious 
stimulation of 12 of 16 Laminae IV or V neurones excited by alter­
nate noxious and non-noxious stimuli. With one neurone, both 
responses were depressed and with the remaining 3 neither was 
affected. Of the 12 neurones, the activation of which by the 
nociceptive stimulus was reduced by morphine, the response to non­
nociceptive stimulation was not significantly changed in 7 and 
increased above controls in 5. With a further 4 neurones, noci­
ceptive responses alone were studied and morphine reduced this 
activation of 3. In Figure 24,for the period between A and C, the 
ability of morphine to reduce the response of one neurone to noci­
ceptive stimulation,independent of effects on spontaneous firing 
or that in response to non-nociceptive stimulation,^ illustrated 
by a plot of response amplitude with respect to time. The actual 
responses A and B in the lower part of this figure, illustrate this 
action more directly (see legend for details).
The temporal relationships of the effects of morphine were 
different from those usually observed when compounds are admin­
istered electrophoretically in the vicinity of cell bodies. 
Firstly, there was considerable variation in the time to onset 
of the reduction of nociceptive activation, this ranging from 
4-35 minutes. Since the relative positions of recording and 
drug administering pipettes varied from neurone to neurone,then 
the administration of varying doses of morphine would be expected
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Fig. 25: Effect of distance between drug administering
and recording pipettes on the dose of morphine, ejected in 
the substantia gelatinosa region, necessary to reduce 
nociceptive activation of dorsal horn neurones. Ordinate: 
charge in \i coulombs passing through the morphine containing 
pipette up to the time of reduction of nociceptive firing. 
Abscissa: distance in pm between the tips of the drug 
administering and recording micropipettes.
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to take different lengths of time to achieve the appropriate 
concentration conditions at the structures within the sub­
stantia gelatinosa region which were being affected. The 
analysis shown graphically in Figure 25 indicates that this 
time to effect was not related simply to the time for morphine 
to diffuse to and have effects at the cell body - a possible 
site of action ruled out by the previous study. In order to 
construct this graph the dose of morphine administered was cal­
culated by multiplying the current passed through the morphine 
containing barrel by the time for reduction in the response to 
nociceptive activation. This calculation makes the assumption 
that the transport number for morphine did not greatly differ 
between pipettes. This dose was then plotted against the 
distance separating the tips of the recording and drug admin­
istering micropipettes and it can be seen that these variables 
are not closely correlated. Neurones to which naloxone had 
been administered some time previously to morphine were omitted 
from this analysis.
Secondly, the reduction of nociceptive activation by 
morphine was long lasting but, because its abrupt reversal by 
intravenous naloxone was considered necessary evidence of 
specificity, the total duration of this depression was not 
determined with any accuracy. In five experiments this 
depression was still unchanged at 17, 50, 12, 56 and 21 min­
utes after cessation of morphine ejection in the SG region.
That morphine was still active at this time was shown by the 
rapid reversal of this depression by intravenous naloxone in 
Figure 24 and also in Figure 26.
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Fig. 26: Prolonged effect of morphine, ejected in the
substantia gelatinosa region in reducing nociceptive 
activation of a dorsal horn neurone and reversal of this 
effect by naloxone administered both electrophoretically 
and intravenously. The neurone was located in spinal 
lamina IV and activated by noxious heat to the fourth 
digital pad of left hind limb. Response amplitude and 
spontaneous firing are plotted with respect to time. The 
times and currents in nA used to eject morphine and 
naloxone are indicated by bars. Between 100 and 110 minutes 
from the start of recording DL-homocysteate was ejected in 
the vicinity of the cell body, but these responses have been 
omitted for clarity.
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(b) Effects of Naloxone
(i) Administered Electrophoretically in Association 
with Morphine.
Naloxonefadministered electrophoretically with 
similar currents and from the same pipettes used to 
administer morphine, reversed the depression by mor­
phine of the nociceptive activation on all 12 neurones 
tested (Fig. 26 and 27). In these tests, naloxone 
ejection was added to that of morphine after the latter 
drug had depressed nociceptive activation and morphine 
ejection continued beyond that of naloxone until this 
response had once more been depressed (Fig. 26 and 27).
Two types of result were obtained. With 4 
neurones, the responses of which to nociceptive stim­
ulation had been depressed by morphine, naloxone 
restored these responses to control levels without 
significant effect on non-nociceptive or spontaneous 
firing. With 8 other neurones, naloxone enhanced 
firing to above control levels and increased spon­
taneous firing as well as that produced by non-noci­
ceptive stimulation on 6 occasions when this was con­
currently tested. As illustrated in Figure 27, the in­
creased firing rates attained during naloxone ejection 
were not brought about merely by an elevation in spontan­
eous firing; the total number of action potentials in 
response to each period of stimulation was increased, the 
increase being greater for nociceptive than for non­
nociceptive stimuli. Figures 26 and 27 also show that 
for morphine to overcome the effects of naloxone, large
100
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Fig. 27: Depression by morphine of nociceptor but not
mechanoreceptor induced firing of a dorsal horn neurone and 
reversal of these effects by electrophoretic naloxone. The 
neurone was located in spinal lamina V and morphine and 
naloxone were ejected in the substantia gelatinosa region. 
Separation between drug administering and recording pipettes 
was 330 ym. The arrangement of plotted cell responses and 
tracings of cell firing are as in Figure 24. The ability of 
electrophoretically administered naloxone to restore the 
response to noxious heat to above control values is also 
illustrated and this effect was also present but to a lesser 
degree with responses to hair deflection.
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ejecting currents for prolonged periods were required, 
and Figure 26 also illustrates that the effects of 
electrophoretically administered naloxone in the 
substantia gelatinosa region can be duplicated with 
intravenous administration.
(ii) Administered Intravenously
Administered following the cessation of morphine 
ejection, intravenous naloxone abruptly reversed, in 
all 4 experiments, the depression of nociceptive 
activation by morphine. In three experiments the 
first dose of naloxone was effective (0.1, 0.3 and 
0.3 mg kg and in the remaining one, two doses of 
0.3 mg kg  ^were necessary. The results from two of 
these experiments have been shown in Figures 24 and 26, 
and to ensure that changed responses following naloxone 
in Figure 24 were not merely due to recovery from 
previous morphine, a second dose of morphine was ad­
ministered in the region of the SG just prior to the 
intravenous naloxone. The abrupt nature of the change 
in the response to nociceptive stimulation in these 
and other experiments confirms that this effect was 
indeed produced by the intravenous antagonist.
Naloxone, administered intravenously (0.5-1.2 
mg kg during the continued ejection of morphine, 
reversed the depression of nociceptive activation by 
morphine in 3 of 6 experiments. All of these results 
were obtained from cells on which the effects of 
morphine had been previously antagonized by electro-
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phoretically administered naloxone, and on which 
prolonged ejection of morphine was necessary to 
overcome the effect of naloxone. In the tests 
where intravenous naloxone had no effect, the 
approximate amounts of morphine previously ejected 
were 150 nA for 90 min, 200 nA for 105 min and 200 
nA for 150 min. For those in which intravenous 
naloxone reversed the effects of morphine the 
amounts were 200 nA for 120 min, 30 nA for 70 min 
and 60 nA for 90 min.
(iii) Effects of Electrophoretically Administered 
Naloxone Alone
As pointed out in previous discussion, naloxone 
is considered amongst the "purest" of opiate anta­
gonists in the sense that it has minimal agonist 
activity in animals (Blumberg, Dayton, George & 
Rapaport, 1961) and man (Lunn, Foldes, Moore &
Brown, 1961; Blumberg & Dayton, 1972). In the 
present experiments, naloxone administered after 
morphine often raised the spontaneous, nociceptive 
and non-nociceptive firing to above control levels.
It therefore became necessary to determine the 
possible excitant properties per se of this compound 
when administered electrophoretically in the SG region.
Eleven neurones were tested in this way, 8 in 
lamina IV, 3 in lamina V.
When ejected with currents similar to those 
required to reverse the effects of morphine, naloxone 
had no effect on the firing of 8 neurones. With 2,
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the levels of each of the three firing parameters 
were elevated to just above controls and with one, the 
spontaneous and nociceptive activation of which alone 
were studied, these two types of firing were also 
elevated.
(c) Effects of Amino Acids
To test the possibility that morphine might be acting by 
exerting a predominantly excitant or depressant effect on 
neurones of the substantia gelatinosa, excitant (L-glutamate, 
DL-homocysteate) and depressant (glycine, GABA) amino acids were 
also ejected in this region. A considerable variation in effects 
of these substances on spontaneous firing and on the responses to 
nociceptive and non-nociceptive stimulation was observed.
An excitant amino acid was administered to the substantia 
gelatinosa on 13 of 16 occasions when morphine was effective in 
reducing nociceptive responses. With 4 neurones no effect on 
any firing pattern was observed even after ejections of up to 
200 nA for 13 minutes; with 3 the spontaneous firing was 
variably increased but the responses to peripheral stimulation 
were unaffected; with 4 spontaneous firing and nociceptive but 
not non-nociceptive responses were increased; with one all three 
firing patterns were increased and with another both the spon­
taneous and nociceptive afferents were reduced. The 3 neurones, 
the responses to nociceptive stimulation of which were unaffected 
by morphine,were all excited by an excitant amino acid but with 
no consistent effect on responses to skin stimulation.
The depressant amino acids were almost without effect. Of 
four neurones on which morphine had reversed responses to
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nociceptive stimulation, glycine or GABA had no effect on 3 
(200 nA for 5 mins) and depressed all the patterns of firing of 
the remainder (30-100 nA, 15 mins). Of 11 other neurones on 
which glycine or GABA were tested, effects were seen on only 2, 
both with GABA, with one other spontaneous alone was reduced 
and with the other spontaneous and the nociceptive response 
were reduced.
On no occasion was specific reduction of nociceptive 
response observed following the ejection of amino acids.
Effects with amino acids, when observed, also exhibited 
a time course different to those of morphine. Although the 
time of onset of any detectable effeet was frequently prolonged 
when compared to administration near the cell body, reversal of 
these effects was usually evident within 2 minutes.
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DISCUSSION
The present investigations have revealed an action of 
electrophoretically administered morphine in the spinal cord 
which shows selectivity in the sensory modality affected, is 
reversible by similarly or intravenously administered naloxone 
and which is exerted at sites distant from the cell body of the 
neurones studied. That these observations are relevant to the 
actions of morphine administered systemically, is supported by 
the following considerations:
1. Sensory Modality Selectivity
The ability of morphine to alleviate pain in humans has 
long been known (for quantitative study see Wolff, Hardy & 
Goodell, 1940). That it does so independent of effects 
on other sensations,also receives support from the clinical 
literature (Wikler, Goodell & Wolff, 1945; Eddy, 194l),
Animal studies have shown that intravenous morphine­
like compounds have selective actions at the spinal cord in 
reducing transmission in small diameter afferent fibres.
Le Bars et a_l. (1975) , using a combination of nociceptive 
natural stimulation and electrical stimulation of large 
diameter cutaneous afferents, found that intravenous mor­
phine (2 mg kg )^ depressed the responses of spinal lamina 
V neurones to the noxious stimulus alone. A similar result 
had been found previously with phenoperidine (Besson et al., 
1973) and fentanyl (Iwata & Sakai, 1971). Other studies 
measuring the effects of intravenous morphine on spinal 
reflexes also report that it more readily reduces those 
produced by impulses in small rather than large diameter
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afferents (Wikler, 1944; Takagi, Matsumura, Yanai &
Ogiu, 1955; Koll, Haase, Block & Mühlberg, 1963; but see 
Krivoy, Kroeger & Zimmerman, 1973).
The present experiments,by demonstrating that morphine 
administered in the region of the substantia gelatinosa 
was specific in reducing firing by nociceptive but not by 
mechanoreceptor afferents,thus show good correlation with 
the effects of systemic morphine. That this apparent 
selectivity was a result of the failure of morphine to 
reach the terminals of mechanoreceptor afferents finds no 
support in the anatomical literature. Although large 
diameter primary afferents curve over the dorsal horn and 
enter the substantia gelatinosa from the ventral side 
(Cajal, 1909), and unmyelinated fibres enter directly from 
Lissauer's tract (Ranson & Billingsley, 1916; Scheibel & 
Scheibel, 1968),the terminals of both types are apparently 
widely distributed throughout the substantia gelatinosa 
(Szentagothai, 1964).
2. Antagonism by Naloxone
While the demonstration that electrophoretically 
administered naloxone antagonized the effects on noci­
ceptive responses of similarly administered morphine might 
suggest relevance to the actions of systemic morphine, the 
unknown concentrations of substances when ejected by electro­
phoresis prevent such a demonstration from being completely 
definitive. The additional demonstration however that 
intravenous naloxone antagonized the actions of morphine 
establishes more firmly the relevance of the observations. 
Indeed, it is important when demonstrating the relevance of 
these effects to those following systemic administration,to
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stress the finding that intravenous naloxone was effective 
in reversing the effect of morphine with doses as low 
as 0.1 mg kg )^ . Doses of this order are effective in 
reversing the effects of analgesic doses of morphine 
in the cat (Jurna & Grossman, 1976) and the dog (McLane 
& Martin, 1967a).
3. Enhancement of Responses by Naloxone to Above Control Levels 
The ability of electrophoretically administered naloxone 
in the present studies to enhance the depressed responses to 
nociceptive stimulation following morphine to above control 
levels in two-thirds of the neurones studied is an action 
which is similar to that reported for intravenous naloxone 
in the literature, and therefore might emphasize further 
the relevance of the present results. Naloxone when given 
intravenously to reverse effects of morphine has been 
reported to elevate responses above control levels at low 
doses (Le Bars et al., 1975; Jurna & Grossman, 1976).
In the present study such an effeet was accompanied by an 
increase in cell excitability as shown by increased spon­
taneous firing and an enhanced response to mechanoreceptor 
stimulation. As naloxone alone did not exhibit such 
activity it appears that this compound has an action,on 
neurones exposed to morphine,different to that on neurones 
not previously exposed. Whether this phenomenon is in 
any way an analogy at the single cell of precipitated 
abstinence (Wikler et al., 1953) is a matter for speculation. 
Although in this context the times of exposure were 
relatively short, recent reports have shown that in mice 
naloxone is able to precipitate a jumping withdrawal 
symptom within 10 minutes of morphine administration
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(Kosersky, Harris & Harris, 1974) and that the number of 
opiate binding sites is increased five minutes after 
implantation of a morphine pellet (Pert & Snyder, 1976).
The long time of onset and duration of the effect of 
morphine in the region of the substantia gelatinosa differs 
from any other report of an effect of this substance 
administered electrophoretically to dorsal spinal neurones. 
The depression of firing reported by Dostrovsky & Pomeranz 
(1973); Calvillo, Henry & Neumann (1974); Satoh, 
Zieglgänsberger, Fries & Herz (1974); Duggan, Davies &
Hall (1976); and Gent & Wolstencroft (1976) was rapidly 
reversible. Depression of brainstem neurones (Bramwell 
& Bradley, 1974) and excitation of Renshaw cells (previously 
reported here) is also rapidly reversible. The relatively 
slow onset of effect by morphine may in part be due to the 
time required to achieve appropriate concentrations of mor­
phine at the relevant sites in the substantia gelatinosa.
It may well be that an interaction of morphine at many sites 
within the substantia gelatinosa is needed before effects 
can be seen. If the axonal arborization of neurones of 
the SG and the dendritic processes of lamina IV neurones 
are as widely ramifying as the literature suggests 
(Szentagothai, 1964; Mannen & Sugiura, 1976), then this 
possibility cannot be ruled out.
A very slow rate of removal of morphine is unlikely to 
explain its prolonged action since the effects, when present, 
of DL-homocysteic acid similarly administered decayed 
relatively quickly. When administered near cell bodies 
the effects both of DL-homocysteate and morphine are 
rapidly reversible, suggesting that both compounds are
readily removed from the extracellular environment. Other 
workers have commented on the long duration of effect of 
morphine given intravenously. Le Bars et ad.., (1976)
reported that intravenous morphine caused a depression of 
the spontaneous and evoked firing of dorsal horn neurones 
which lasted greater than 40 minutes, the depression of 
the flexor reflex of the dog by intravenous morphine 
which was observed by McClane & Martin (1967b) to become 
maximal after 1 hour, remained at that level for over 4 
hours. Administered intraventricularly to rabbits, the 
analgesic action of morphine is more prolonged than when 
administered intravenously, a difference attributed to 
the difficulty with which the hydrophilic morphine molecule 
penetrates nervous tissue (Herz & Teschemacher, 1971).
This latter property is unlikely to explain the prolonged 
effect of morphine in the present results since effects 
observed following the administration of DL-homocysteate, 
which is readily soluble in water, were rapidly reversible. 
These considerations suggest a slow dissociation from the 
opiate receptor in the substantia gelatinosa.
The anatomical localization of the opiate receptor 
studied in the present experiments is not known. Auto-
3radiographic studies of systemically injected H- 
diprenorphine (Pert, Kuhar & Snyder, 1975) have shown 
the substantia gelatinosa to be amongst the highest opiate­
binding sites in the central nervous system of the rat.
The method was not adequate to determine the fine structural 
basis of binding but, in all labelled regions, silver grains 
were located between cell bodies and not over them. Such 
a finding correlates well with the previous studies where
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administration of morphine to the cell body regions of 
dorsal horn neurones activated by noxious stimuli gave 
results bearing no relation to the effects of systemic 
morphine. Studies on the monkey have shown the upper 
dorsal horn (which includes the substantia gelatinosa) to 
be a region of high stereospecific binding of opiates, and 
that sectioning of the dorsal roots results in a significant 
reduction in such binding (Lamotte, Pert & Snyder, 1976). 
This finding is consistent with the localization of 
receptors on terminals of primary afferent fibres but 
cannot exclude loss of receptors associated with trans- 
synaptic degeneration of neurones.
Because of the complexity of organization of the 
substantia gelatinosa, any of the following mechanisms 
could explain the effects of morphine observed in the 
present experiments:
1. Inhibition of transmitter release from the terminals 
of nociceptive afferents. This could be produced 
by block of conduction in fine terminals or activity 
at axo-axonic synapses known to be abundant in the 
substantia gelatinosa (Rethelyi & Szentagothai, 1969).
2. Block of the postsynaptic action of the transmitter 
released by nociceptive afferents. Although this 
transmitter has not been identified, some evidence 
has accumulated which implicates a transmitter role 
for substance P an undecapeptide at the terminals of 
small diameter primary afferents (Hökfelt, Kellerth, 
Nilsson & Pernow, 1975; Otsuka, Konishi & Takahashi, 
1975). The relevant receptors could be located on 
the dendrites of neurones of deeper spinal laminae or
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on neurones of the substantia gelatinosa.
3. Depression of excitatory interneurones or excitation 
of inhibitory neurones of the substantia gelatinosa.
The results with excitatory and inhibitory amino 
acids in the present experiments do not favour this 
explanation.
The use of the two-electrode technique in the present 
investigations enabled administration at sites distant 
from cell bodies. The value of this technique may provide, 
as some workers have found, a valuable tool for elucidating 
the importance to neuronal activation of dendritic receptors 
(Diamond, 1968; Dudar, 1968; Ransom & Nelson, 1975) and 
neighbouring neurones (Biscoe & Curtis, 1967; Renaud & 
Kelly, 1974a, b; Headley, Lodge & Duggan, 1976).
The importance of the present investigation lies in 
the demonstration of the effects of electrophoretically 
administered morphine which can be related to analgesia 
following systemic opiates. Because of this,the technique 
offers a means of investigating the physiological role, if 
any, of the polypeptides which compete with morphine for 
stereospecific receptor sites in brain homogenates 
(Terenius & Wahlström, 1975).
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EFFECTS OF OPIATE AGONISTS AND ANTAGONISTS 
ON NEURONES OF THE MEDIAL THALAMUS
Pharmacological investigations of medial thalamic neurones 
described here were embarked upon initially in an attempt to 
determine the activity of opiate compounds in this region.
The fact that the medial thalamus had been implicated in the 
central organization of nociceptive information and mechanisms 
of analgesia (see later discussion), rendered it a likely site 
for the interaction of morphine-like substances with central 
neurones.
Preliminary studies,aimed at characterizing the responses 
of neurones of the medial thalamus to electrophoretically 
administered putative transmitter compounds (previously 
unreported) and to electrical foot-pad stimulation,were carried 
out. The unexpected actions of acetylcholine in these investi­
gations however, warranted an extended study which has been 
published (Duggan & Hall, 1975).
(i) INHIBITION OF MEDIAL THALAMIC NEURONES BY ACETYLCHOLINE 
Introduction
Early studies of the sensitivity of thalamic neurones 
to electrophoretically administered substances (Andersen & 
Curtis, 1964a and b), revealed that acetylcholine excited 
ventrobasal neurones and the receptors had properties which 
were intermediate between nicotinic and muscarinic, similar 
to those of lateral geniculate neurones (Curtis & Davis, 
1963) and neurones in the medullary reticular formation 
(Salmoiraghi & Steiner, 1963). Further studies have
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confirmed the pharmacological properties of these thalamic 
neurones (McCance, Phillis, Tebecis & Westerman, 1968) 
and along with other reports which suggest the possibility 
of cholinergic projections to the thalamus (Shute & Lewis, 
1963; Austin & Phillis, 1965; Phillis, 1968), provide 
evidence that acetylcholine may have a function in synaptic 
transmission processes (see Phillis, 1971).
As pharmacological information,similar to that 
described above for ventrobasal neurones,has not been 
reported for the medial thalamic group, the present study 
was undertaken to define the pharmacological responses of 
neurones in these regions.
Most animals in these thalamic experiments were 
anaesthetized with a-chloralose, one animal with 
pentobarbitone and all were artificially respired. No
difference occurred between a-chloralose or barbiturate 
naesthetized animals in the type of effects observed.
HORSLEY-CLARKE +7
LAT GEN
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MED GEN
PF-CM
Fig . 28: A diagramatic representation of some
thalamic nuclei in sagital section at the +7 Horsley- 
Clarke co-ordinate. PF-CM, Parafascicularis-Centre 
Median Complex; LAT POST, Lateralis Posterior Nucleus;
VPM, Ventralis Postero-Medialis; MED GEN, Medial Geniculate; 
LAT GEN, Lateral Geniculate. A seven barrel micropipette 
is also illustrated.
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RESULTS
Neurones of the centre-median parafascicularis (CM-PF) 
complex were sought as described in Chapter II. The depos­
ition of dye indicated that neurones in the medial part of 
nucleus dorsomedialis were also studied. These nuclei are 
represented diagramatically in Figure 28 although the histol­
ogical sections did not permit accurate nuclear limits to be 
defined. Physiological characterization of neurones in terms 
of nuclei was also not possible and neurones studied responded 
to peripheral stimulation with latencies of 15-70 msec as 
previously reported (McKenzie & Rogers, 1973). All cells 
responded to stimulation of more than one limb. With most 
neurones, the presence of spontaneous bursts of firing 
(spindles, Andersen & Sears, 1964) markedly influenced the like­
lihood of this response to foot pad stimulation; not only did 
the position of the stimulus in relation to the various phases 
of the spindle affect the response (Andersen & Sears, 1964), 
but many neurones could not be activated at all between 
spindles.
(a) The Effects of Acetylcholine 
(i) Spontaneous Firing
Spontaneous activity, commonly in the form of 
spindling, was exhibited by 63 of 66 neurones studied 
in the region of the centre median (CM), para- 
fascicularis (PF) and lateralis posterior (LP) nuclei. 
Acetylcholine, ejected with currents of 35-100 nA, 
depressed the firing of 41 neurones, excited 10 and 
had no effect on 15 neurones, three of which had no
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Fig. 29: Effects of acetylcholine on spontaneous firing,
excitation by L-glutamate and evoked firing of thalamic neurones. 
A. Depression of spontaneous firing by ejection of acetylcholine 
60 nA (ACH), y-aminobutyric acid 35 nA (GABA) and acetyl-$-methyl- 
choline 80 nA (AC 3 ME) and lack of effect by ejection of sodium 
80 nA (Na+). B. Depression of spontaneous firing but enhancement 
of excitation by L-glutamate. C. Depression by acetylcholine, of 
firing evoked by a stimulus to the ipsilateral forepaw. Each 
record is a post-stimulus time histogram composed of 64 sweeps 
with an analysis interval of 5 ms. An arrow marks the position of 
the stimulus. Stimulus frequency 0.3 Hz. Records B and C are 
from the same cell.
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spontaneous activity.
It was possible to relate the response to acetyl­
choline to the type of spontaneous activity. Forty- 
five neurones showed spontaneous spindles and were 
evoked inconstantly by peripheral stimulation and 
with a relatively long latency (30-60 msec). Of 
these,the spontaneous firing of 38 was depressed by 
acetylcholine, none were excited and that of seven 
unaffected. In Figure 29A the depression of one 
neurone's spontaneous spindles by acetylcholine,
GABA and acetyl-3-methylcholine and lack of effect 
by ejection of sodium ions is depicted. Four neurones 
exhibiting spontaneous spindle activity, but responding 
constantly to peripheral stimulation and with relatively 
short latency (12-20 msec), were excited by acetyl­
choline. Fourteen neurones fired irregularly without 
spindles and of these, 3 were depressed by acetylcholine, 
6 excited and 5 unaffected.
(ii) Excitation by L-glutamate
Since the spontaneous firing rates of the majority 
of neurones sampled were quite low (e.g. as in Figure 
29A), excitation by L-glutamate was initially attempted 
to demonstrate more clearly the depressant action of 
acetylcholine. The results were unexpected. Of 17 
neurones, the spontaneous firing of which could be 
depressed by acetylcholine, excitation by L-glutamate 
was enhanced in 14, depressed in 2 and unaffected in 1.
Excitation by L-glutamate was enhanced concurrently 
with a depression of spontaneous firing on 14 of 17 
neurones, the responses of 2 being depressed and the
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remaining neurone being unaffected. This effect 
was observed in 9 animals using 10 different micro­
pipettes. Figure 29B illustrates on the same cell 
the depression of spontaneous firing, but the 
enhancement of the response to L-glutamate, during 
the ejection of acetylcholine.
(iii) Peripheral Activation
Peri-stimulus histograms,prepared from the 
responses of spindling neurones to electrical 
stimulation of the foot pads,revealed both early and 
late components (Fig. 29C). The early phase had a 
latency of 20-60 msec and was the firing used to 
identify neurones. Of 7 neurones analysed in this 
manner, the early and late evoked firing of 5 was 
depressed by acetylcholine (40-60 nA) and that of 2 
unaffected. Figure 29C shows a 45% decrease in the 
early firing and near complete abolition of late 
firing, both effects being reversible. These records 
were obtained from the same neurone as those of 
Figure 29B.
(b) Effects of Cholinomimetics
In an attempt to characterize the nature of the 
depressant effect of acetylcholine,a nicotinic and 
muscarinic agonist was tested for effects on neurones 
inhibited by acetylcholine.
Nicotine (30-50 nA) depressed the spontaneous spindle 
activity of 5 of 6 neurones and acetyl-8-methylcholine 
(70-90 nA; Fig. 29A) depressed spontaneous spindle 
activity of 4 neurones tested. The time course of
DH ß E 50nA
L-GLUT 55 nA
ACETYLCHOLINE 60nA
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Fig . 3 0: The reversal by dihydro-(3-erythroidine (DH3E)
of the potentiation of L-glutamate (L-GLUT) and suppression
of spindles caused by the ejection of acetylcholine.
The breaks in the ratemeter record represent periods 
of 1Jg and 4^ minutes respectively.
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responses to both these cholinomimetics was similar to 
that of acetylcholine.
(c) Effects of Acetylcholine Antagonists
Dihydro-3-erythroidine (DHßE), a nicotinic antagonist, 
was ejected with currents of 10-40 nA and reversibly 
antagonized both effects of acetylcholine, depression of 
spontaneous spindles (5 of 8 neurones) and enhancement of 
excitation by L-glutamate (2 of 2 neurones). This action 
by DH8E is illustrated in Figure 30.
Atropine antagonized depression of spindles by acetyl­
choline on the two occasions tested.
On no occasion did either of these two substances 
alter the magnitude of the spindle response or the fre­
quency of spindling.
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DISCUSSION
Inhibition of thalamic neurones by acetylcholine,to the 
extent described in the present study, has not previously been 
reported. In early investigations of the pharmacological 
responses of ventrobasal thalamic neurones, excitation by 
acetylcholine was the predominant effect, although an initial 
inhibition of several cells was observed (Andersen & Curtis, 
1964b). Depression by acetylcholine was an uncommon finding 
with neurones of the lateral geniculate (Phillis, Tebecis &
York, 1967; Satinsky, 1967) and in a survey of several other 
thalamic nuclei (McCance, Phillis & Westerman, 1968). Tebecis 
(1970) reported however that 40% of medial geniculate neurones 
were depressed by acetylcholine and more recently up to 60% of 
neurones in the anterior pulvinar and nucleus lateralis 
posterior regions were found to be depressed by this substance 
(Godfraind, 1975). A recent study of neurones of the feline 
nucleus reticularis has also reported a considerable proportion 
of neurones to be inhibited by acetylcholine (Ben Ari, Kanazawa 
& Kelly, 1976) .
The receptor associated with inhibition of medial thalamic 
neurones in the present study exhibited a mixed nicotinic/ 
muscarinic pharmacology, as has also been found for other 
receptors mediating inhibition of medial geniculate neurones 
(Tebecis, 1972) and superficial cortical neurones (Phillis & 
York, 1968). The most commonly observed type of inhibition 
mediated by acetylcholine involves receptors of a predominantly 
muscarinic nature and has been reported in many regions of the 
CNS (supraoptic nucleus, Barker, Crayton & Nicoll, 1971; 
cerebral cortex, Randic, Siminoff & Straughan, 1964; Phillis
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& York, 1968; Stone, 1972; medulla oblongata, Bradley,
Dhawan & Wolstencroft, 1966; spinal cord, Curtis, Ryall &
Watkins, 1966).
In invertebrate central neurones the inhibitory action of 
acetylcholine is believed to be a postsynaptic effect, the 
result of which is a change in the chloride conductance of the 
postsynaptic neurone (Chiarandini & Gerschenfeld, 1967). The 
mechanism of cholinergic inhibition in the mammalian CNS is yet 
to be described (see Krnjevic, 1974), but the differential effect 
of acetylcholine on spontaneous firing and on that produced by 
an excitant amino acid in the present study has not been reported 
previously and points to a presynaptic action. If it is assumed 
that excitation by L-glutamate is a postsynaptic action (Curtis, 
Duggan, Felix, Johnston, Tebecis & Watkins, 1972), then 
potentiation of this effect by acetylcholine is most simply 
explained in terms of acetylcholine also being a postsynaptic 
excitant, as there is no evidence that cholinomimetics interfere 
with the uptake of L-glutamate by rat brain slices (Balcar & 
Johnston, 1972). In view of this effect, a reduction of the 
spontaneous spindles by acetylcholine is most probably an 
effect on presynaptic structures,as such firing in ventrobasal 
and centralis lateralis neurones has been shown to be associated 
with sequences of excitatory and inhibitory postsynaptic 
potentials (Andersen & Sears, 1964). The other possible 
explanation is that acetylcholine blocks the postsynaptic 
action of the naturally released transmitter which is not 
L-glutamate.
The "presynaptic" effect of acetylcholine may involve the 
following mechanisms:
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1. Depolarization of nerve terminals. This would 
result in a decreased output of the natural transmitter 
as has been described by Hubbard & Willis, (1962) and 
Eccles, (1964) .
2. Excitation of inhibitory neurones. The firing of 
adjacent neurones which were inhibitory to the neurone 
under observation would result in a depressant effect 
being ascribed to acetylcholine,but such an effect alone 
would be unlikely to differentiate between synaptic and 
L-glutamate induced firing. A differential effect might 
arise if the proposed adjacent neurones were on a pathway 
for presynaptic inhibition. L-glutamate, however, excites 
neurones widely in the mammalian central nervous system 
(Curtis et al_. , 1972) and failure to observe similar 
inhibition with this substance implies that there are marked 
differences between the cells studied and the proposed 
adjacent inhibitory neurones in their sensitivity to 
acetylcholine.
3. Inhibition of adjacent neurones which were excitatory
to the cells studied. Again this mechanism would fail 
to produce a differential effect by acetylcholine on the 
synaptic and L-glutamate induced firing.
There is evidence that acetylcholine has a presynaptic 
depolarizing action at the mammalian neuromuscular junction 
(Riker & Okamoto, 1969), frog sympathetic ganglia (Riker, 1968) 
and at central molluscan neurones (Woodson, Schlapfer, Tremblay 
& Barondes, 1975). At all of these synapses, where acetyl­
choline is believed to be the transmitter mediating postsynaptic 
excitation, the consequence of this presynaptic action is an 
impairment of transmission.
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The finding in the present study of an inhibitory action 
of acetylcholine on medial thalamic neurones is of interest 
when considered with other studies where the predominant effect 
of this ester and possible transmitter is reported to be 
excitation (Andersen & Curtis, 1964a). The possible functional 
significance of this finding requires further experimentation. 
Firing in spindles by thalamic neurones is not seen in conscious 
animals but is associated with slow wave sleep and anaesthesia 
(Filion, Lamarre & Cordeau, 1971). Acetylcholine, along 
with its synthetic and degradative enzymes, has been shown to be 
present in the thalamus (Macintosh, 1941; Feldberg & Vogt,
1948; Zetler & Schlosser, 1955; Hebb & Silver, 1956; Burgen 
& Chipman, 1951, 1952; Koelle , 1954; Gerebtzoff, 1959), 
however it remains to be shown that a functional role of this 
putative transmitter,possibly as part of the "ascending 
activating system" (see Brodal, 1969), is related to its 
suppression of medial thalamic neurones.
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(ii) ACTIONS OF OPIATE AGONISTS AND ANTAGONISTS ON 
MEDIAL THALAMIC NEURONES
Introduction
Although a previous section of this thesis reports 
evidence favouring a role for the spinal cord in the 
mechanism of morphine analgesia, other brain regions are 
probably affected by systemic opiates (see Concluding 
Remarks).
The medial thalamus is one such area and on both 
anatomical and physiological grounds is believed important 
in the appreciation of nociceptive information. These 
nuclei have been shown by degeneration studies to receive 
spinothalamic extralemniscal projections (cat, Anderson 
& Berry, 1959; Boivie, 1971; monkey, Mehler, et al.
1960; Bowsher, 1961). There is some doubt over the 
existence of direct spinal projections to the centre-median 
nucleus (see Kerr & Lipman, 1974) and the possibility that 
spinothalamic projections to this nucleus are polysynaptic 
via bulbar and pontine nuclei is most likely (see Bowsher, 
1966). Additional support for these anatomical findings 
comes from reports of diminished sensitivity to pain which 
follows lesions of this area (in particular the centre- 
median, parafascicularis complex) both in animals (Mitchell 
& Kaelber, 1966; Marburg, 1973; Kaelber, Mitchell,
Yarmat, Afife & Lorens, 1975) and man (Hecaen, Talairach, 
David & Dell, 1949; Mark & Ervin, 1969). Chang (1973) 
has also suggested from electrophysiological studies a 
role of these nuclei in the analgesia resulting from 
acupuncture.
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On physiological grounds, the medial thalamus has also 
been suggested to be important in nociception. Albe- 
Fessard & Kruger (1962) recording from single units in the 
centre-median, demonstrated that "noxious" stimuli and 
not those produced by hair bending, light touch or muscle 
stretch excited these neurones. Similarly Woda, Azerad, 
Guilbaud & Besson (1975) were able to elicit responses of 
single neurones of the medial thalamic nuclei by stim­
ulation of the dental pulp of the cat, a procedure 
believed to elicit a purely painful sensation (Windle,
1927; Brookhart, Livingston & Haugen (1953).
It is not surprising that such an area has attracted 
interest as a site where morphine-like drugs might interact 
with central neurones in the production of analgesia.
Indeed evidence supporting such a possibility has accum­
ulated from micro-application experiments (Yeung, Yaksh 
& Rudy, 1975), and opiate binding studies (Kuhar, Pert & 
Snyder, 1973). Differences however,have been observed 
between morphine and meperidine in their effects on 
gross potentials recorded in the centre-median (Millan 
& Besson, 1964).
The present investigations examined the effects of 
morphine and naloxone on the firing patterns of single 
neurones of the centre-median (CM), parafascicularis (PF) 
and lateralis posterior (LP) nuclei when administered 
both electrophoretically and intravenously. Animals 
were anaesthetized with a-chloralose and were artificially 
respired.
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RESULTS
(a) Morphine and Naloxone Administered Electrophoretically 
(i) Spontaneous Firing
The effects of morphine were studied on 32 
cells which fired spontaneously with a spindle 
pattern. Ejected with currents of 20-100 nA, mor­
phine had no effect on the firing of 18 neurones, 
weakly depressed that of 13 and excited 1 (Fig. 31B).
In no case did the available currents produce greater 
than 75% inhibition of firing, and by comparison , 
relatively low currents of acetylcholine (Fig. 31A, B) 
and GABA were more potent depressants.
Naloxone (15-100 nA), weakly depressed the spon­
taneous firing of 7 neurones (Fig. 31A) and had no 
effect on that of 18. Owing to the weak and in­
consistent depression by morphine, on only 6 occasions 
could quantitative tests of possible antagonism by 
naloxone be performed and in no case was this observed. 
(ii) Firing Evoked by Electrical Stimulation of Forepaws 
To assess the effects of electrophoretically 
administered morphine and naloxone on evoked firing, 
peri-stimulus time histograms were prepared. The 
more medially located cells of the centre-median 
parafascicularis complex responded to stimuli to 
the forepaws with a relatively short latency (15-20 ms) 
and constantly. Cells of the nucleus lateralis 
posterior region fired with a longer latency (20-80 ms) 
and the presence of spindles markedly influenced the 
probability of a response,as reported in the previous
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F i g . 3 1 : E f f e c t s  o f  e l e c t r o p h o r e t i c  m o r p h i n e  and
n a l o x o n e  on  s p o n t a n e o u s  a nd  c h e m i c a l l y  i n d u c e d  f i r i n g  o f  
m e d i a l  t h a l a m i c  n e u r o n e s .  E a c h  t r a c e  i s  a pen  r e c o r d i n g  
o f  c e l l  f i r i n g  m e a s u r e d  w i t h  a r a t e  m e t e r .  O r d i n a t e s ; 
f i r i n g  f r e q u e n c y  i n  s p i k e s  p e r  s e c o n d .  A b s c i s s a e : t i m e  
i n  m i n u t e s .  The b a r s  i n d i c a t e  t h e  t i m e s  o f  e j e c t i o n  o f  
compounds  e l e c t r o p h o r e t i c a l l y . A. D e p r e s s i o n  o f  
s p o n t a n e o u s  f i r i n g  by a c e t y l c h o l i n e  25 nA (ACH), m o r p h i n e  
70 and  100 nA and  n a l o x o n e  80 nA. B.  E n h a n c e d  e x c i t a t i o n  
by L - g l u t a m a t e  f o l l o w i n g  e j e c t i o n  o f  m o r p h i n e .  T h r e e  
s e g m e n t s  o f  c e l l  f i r i n g  a r e  i l l u s t r a t e d  b e i n g ,  f r om l e f t  
t o  r i g h t ,  c o n t r o l  r e s p o n s e s  t o  e j e c t i o n  o f  L - g l u t a m a t e  
60 nA (L-GLUT),  r e s p o n s e s  d u r i n g  a nd  a f t e r  e j e c t i o n  o f  
m o r p h i n e  50 nA, and  r e s p o n s e s  9 m i n u t e s  l a t e r .  M o r ph i n e  
was  e j e c t e d  f o r  a t o t a l  o f  8 m i n u t e s  o n l y  o ne  m i n u t e  o f  
w h i c h  i s  i l l u s t r a t e d .  C.  E n h a n c e d  e x c i t a t i o n  by 
L - g l u t a m a t e  f o l l o w i n g  e j e c t i o n  o f  n a l o x o n e .  N a l o x o n e  was 
e j e c t e d  f o r  a t o t a l  o f  6 m i n u t e s ,  n o t  a l l  o f  w h i c h  i s  
i 1 l u s t r a t e d .
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section. Histograms were prepared from both types 
of cell with similar results.
Morphine (30-80 nA) significantly reduced the 
evoked firing of 9 cells and had no effect on that of 
3. With 7 of the cells depressed by morphine, 
possible antagonism by electrophoretic naloxone was 
tested but observed in only 1 instance; in all others 
naloxone was a depressant of firing at least as 
potent as morphine, and the effects were additive 
and not antagonistic.
(iii) Responses to Acetylcholine
Morphine potentiates the excitation of ventro- 
:basal thalamic neurones by acetylcholine, an effect 
antagonized by naloxone (Duggan, Davies & Hall, 1976). 
A similar action by morphine on medial thalamic 
neurones might be expected to result in a diminished 
responsiveness to peripheral stimuli as these cells 
are inhibited by acetylcholine (preceding section; 
Duggan & Hall, 1975).
Very little, if any, interaction between acetyl­
choline, morphine and naloxone was observed. Naloxone 
reversed the depression of firing by acetylcholine 
on only 2 of 15 neurones; and morphine enhanced 
depression by acetylcholine on 1 of 8 neurones tested. 
Two neurones were excited by acetylcholine and mor­
phine enhanced this effect.
(iv) Excitation by L-Glutamate
In contrast to the weak effects on spontaneous 
and evoked firing, interactions of electrophoretically 
administered morphine with excitation by L-glutamate,
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when present, were marked. Of 18 neurones tested, 
excitation by L-glutamate, together with spontaneous 
firing, was depressed in 6 cases, enhanced in 2 and 
unaffected in 10, during ejection of morphine 
(30-80 nA). Immediately following the period of 
morphine ejection however, a large (up to 300%) 
and long lasting (8-43 min) increase in L-glutamate 
sensitivity occurred with the 8 cells, the responses 
of which had been altered during morphine ejection. 
Results from one are illustrated in Figure 31B. The 
duration of this effect was not determined with any 
accuracy as with 6 neurones the L-glutamate response 
was still enhanced when recording conditions did not 
permit accurate counting of neuronal firing rates.
As this enhanced sensitivity to L-glutamate 
occurred after and not during morphine ejection, the 
following experiments were performed to investigate 
the possible relevance of this phenomenon to the 
syndrome produced in humans after withdrawal of 
morphine.
1. In the dependent animal, withdrawal symptoms 
can be produced by administration of a narcotic 
antagonist (Martin, 1967). In the present 
experiments when the responses of cells to 
L-glutamate had been depressed by morphine, the 
added ejection of naloxone did not enhance the 
sensitivity to L-glutamate. These substances 
were additive as depressants of L-glutamate 
evoked firing.
2. Subsequent doses of morphine during the
AP + 7
Fig. 32: The positions marked with filled circles
indicate, on the outline of a brain section at Horsley-Clarke 
+7 co-ordinates, the location of 14 neurones on which studies 
of the effects of intravenous morphine and naloxone were 
carried out. The abbreviated anatomical features are HIP TR 
habenular interpeduncular tract; MB mammillary bodies; LG 
lateral geniculate.
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period of enhanced L-glutamate sensitivity pro­
duced an immediate depression of activity. 
Similar currents of naloxone, however, also 
depressed the enhanced L-glutamate responses. 
Ejection of sodium ions was without effect thus 
excluding the possibility that the effects
observed were due to current alone.
similar to that
Enhanced sensitivity to L-glutamate- following 
ejection of morphine was also observed with naloxone. 
Of 12 neurones tested, the responses of 4 to L- 
glutamate were reduced by ejection of naloxone and 
with 3 of these long lasting enhanced sensitivity to 
L-glutamate was observed following the period of 
naloxone ejection (Fig. 31C) .
The ejection of GABA with currents adequate to 
produce depression both of L-glutamate firing and 
spontaneous spindles was not followed by enhanced 
sensitivity to L-glutamate.
(b ) Morphine and Naloxone Administered Intravenously
The present study investigated the effects of intra­
venously administered morphine and naloxone on the firing 
patterns of medial thalamic neurones, the locations of 14 
of which are shown in Figure 32. Three types of firing 
pattern were studied:
(i) Spontaneous Firing
Twelve cells fired spontaneously with a spindle 
pattern, and neither intravenous morphine nor sub­
sequently administered naloxone had any significant 
effect on such firing in ten experiments (Fig. 33).
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In two experiments morphine (0.5 mg kg ) disrupted 
the spindle pattern resulting in increased irregular 
spontaneous firing, an effect reversed by naloxone.
(ii) Firing Evoked by Electrical Stimulation of Forepaws
As discussed previously, the responses of cells 
of this region of the thalamus vary considerably in 
constancy and latency. Three neurones located 
medial to the habenulo-interpeduncular tract responded 
constantly to the stimulus with a latency of 13-15 ms. 
Intravenous morphine (1.5 mg kg  ^total) significantly 
reduced the responses of one cell but had no effect 
on the remaining two. Naloxone (0.3 mg kg 
administered from 9 to 35 minutes after morphine not 
only reversed the depression of evoked responses by 
morphine but enhanced them above control levels.
Four cells, more laterally situated, responded with 
a longer latency and the probability of a response 
was influenced by the presence of spindle-like 
firing. In no case did morphine (1.5-2.5 mg kg 
influence the total number of evoked action potentials, 
but with one neurone the latency of activation 
increased from 65 to 90 ms following morphine 1.0 
mg kg ^, and this was reversed by naloxone.
(iii) Excitation by L-glutamate
This series of experiments was prompted by the 
long lasting increase in L-glutamate sensitivity 
observed following the electrophoretic administration 
of morphine.
In 7 of 10 experiments the sensitivity of medial 
thalamic neurones to L-glutamate was reduced by a
MORPHINE 0.5mg/kg
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Fig. 33: Depression of sensitivity to L-glutamate by
intravenous morphine and its reversal by naloxone. The 
times of electrophoretic ejection of L-glutamate (60 nA) 
and y-aminobutyric acid (GABA) 20 nA are indicated by 
the continuous and interrupted bars respectively.
Fifteen minutes elapsed between the taking of the upper 
and lower records. Note the change in the ordinate 
scales between the two records. The last illustrated 
response to L-glutamate exceeded the full deflection of 
the pen recorder.
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dose of morphine as low as 0.5 mg kg-1, and was 
completely restored or enhanced above control levels 
by subsequent naloxone (0.2-0.5 mg kg-1). To 
ensure that such changes were not produced merely by 
alterations of the distance between the micropipette 
and the cell, as a consequence of the circulatory 
effects of morphine, in 9 experiments the ejection of 
L-glutamate was alternated with that of GABA, but no 
reversible effect on depression of spontaneous firing 
by GABA was observed following morphine and naloxone. 
Furthermore, the onset of changes in blood pressure 
did not correlate with changes in sensitivity to 
L-glutamate. Results from one experiment are shown 
in Figure 33. The sensitivity of this neurone to 
GABA gradually increased throughout the period 
illustrated, in contrast to that to L-glutamate 
following morphine and naloxone. This observation 
excludes the possibility that the circulatory effects 
of morphine and naloxone produced artifactual changes 
in the sensitivity to L-glutamate. The changes in 
sensitivity to L-glutamate occurred within four 
minutes of injecting morphine and naloxone in all but 
one experiment. In this instance, two doses of 
naloxone (0.3 and 0.2 mg kg 1) were given at an 8 
minute interval, and the sensitivity to L-glutamate 
returned 5 minutes after the second dose.
The observed reduction in sensitivity to L-gluta­
mate occurred in the absence of any significant change 
in spontaneous spindle-type firing in nine experiments. 
In the tenth the spindles were disrupted and the mean
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spontaneous firing rate was increased. In only one 
instance was synaptic activation (by foot pad 
stimulation) concurrently studied owing to the 
requirement that reproducible electrophoretic 
administrations of a compound require it to be 
ejected for fixed times and at fixed intervals.
Synaptic activation in this case was not significantly 
altered despite a reduction in L-glutamate sensitivity.
9 7
DISCUSSION
The present study shows that morphine when administered 
electrophoretically is a weak depressant of neurones of the 
centre-median, parafascicularis and lateralis posterior 
nuclei. The finding however, that naloxone similarly 
administered has the same action or is without effect, renders 
unlikely the possibility that this observed effect of morphine 
is relevant to its effect when administered systemically.
The possible limitation of the electrophoretic technique in 
such situations will be discussed subsequently.
From investigations where interactions of morphine or 
naloxone with acetylcholine were tested, evidence for agonist 
and antagonist activity at presynaptic receptors for acetyl­
choline was not obtained. The finding in the previous section, 
that these cholinergic receptors are mixed nicotinic-muscarinic 
in nature, whereas previous evidence (Chapter III) has shown 
that the cholinergic receptors where morphine and naloxone exert 
agonist and antagonist actions respectively are those possessing 
predominantly nicotinic properties and which are postsynaptic, 
is not sufficient explanation for the present results. The 
former type of receptor is also present on ventrobasal thalamic 
neurones, the studies of which in this laboratory have revealed 
similar effects of morphine and naloxone as on Renshaw cells 
(Duggan, Davies & Hall, 1976).
The increase in sensitivity to L-glutamate following 
morphine ejection has been observed before in a study of cere­
bral cortical neurones (Bioulac, Lund & Puil, 1975), but not 
for the duration observed in the present study. A simple 
explanation for this long lasting elevated sensitivity to
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L-glutamate is that morphine is able to exert a dual action - 
short lasting depression and long lasting increase in cell 
excitability. An alternative explanation, that morphine 
brings about a reduced inactivation of L-glutamate, presumably 
by inhibition of uptake processes would also explain the pro­
longed enhanced sensitivity to this amino acid. In vitro 
studies however, have shown no effect by morphine on these 
processes (Balcar & Johnston, 1972).
Frederickson, Norris, Hewes (1975) have recently provided, 
from studies in the rat, the only other report of the effects 
of an electrophoretically administered opiate compound on 
medial thalamic neurones. They reported that naloxone was 
able to both excite and depress these neurones. This work 
is difficult to compare with the present results: different
species were used and spontaneously active and not synapt- 
ically activated neurones were sampled.
The significant finding of the present investigations 
is the reduction by intravenous morphine of the sensitivity 
of medial thalamic neurones to L-glutamate and its reversal 
by naloxone. Depression of cell excitability by morphine is 
the simplest explanation for its effect, this being brought 
about by a direct action of morphine on the cell membrane or 
indirectly via inhibitory synaptic influences from other 
neurones. The former effect could be produced by a direct 
effect on membrane conductance or a local anaesthetic effect, 
a property that has been demonstrated with high concentrations 
of morphine-like compounds (Simon & Rosenberg, 1970) but which 
is neither stereospecific (Seeman, Chou Wong & Moyyen, 1972) 
nor reversed by antagonists (Simon & Rosenberg, 1970). The 
reduction of cell excitability, however, whether a consequence
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of this property of morphine or of inhibitory synaptic 
influences from adjacent neurones, could be expected to 
reduce spontaneous firing and this was not observed. It 
is possible that the spindle type of spontaneous firing, 
when compared to excitation by electrophoretically admin­
istered L-glutamate, is an insensitive gauge of cell firing 
because it is the result of intense excitatory and inhibitory 
postsynaptic potentials (Andersen & Sears, 1964). The find­
ing, that GABA administered electrophoretically reduces both 
of these types of firing in parallel howeverfrenders this 
possibility unlikely. These considerations lead to the pro­
posal that morphine directly depressed the sensitivity of a 
proportion of neurones studied to L-glutamate, independent of 
any change in basal excitability.
The finding that the reduction in sensitivity to 
L-glutamate by morphine administered electrophoretically was 
not antagonized by similarly administered naloxone is diffi­
cult to reconcile with results obtained employing the intra­
venous route of administration. The most likely explanation 
which accounts for the results reported here is that 
L-glutamate and the morphine-like compounds,when administered 
from micro-pipettes, differ considerably in diffusion through 
nervous tissue and fail to attain the distribution appropriate 
to that achieved when morphine is administered intravenously. 
Another possible explanation,which is suggested by previous 
findings, is that microelectrophoretic administration failed 
to achieve adequate concentrations of morphine at sites, 
perhaps dendritic, distant from cell bodies. A detailed 
study of the cytoarchitecture of neurones of this region 
(Scheibel & Scheibel, 1966) has shown that the dendritic
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processes radiate from the cell body, are poorly ramified and 
of varying length.
Investigations on spinal neurones reported previously 
in this thesis, and together with those by Dostrovsky &
Pomeranz (1973), Calvillo, Henry & Neumann (1974) and 
Zieglgänsberger, Satoh & Bayer1(1975), have also shown the 
ability of electrophoretically administered morphine to reduce 
excitation by L-glutamate. The results reported previously 
here have shown that this effect by morphine could not be 
reversed by naloxone. Some workers have reported such 
antagonism (Calvillo et a]^ . , 1974; Zieglgänsberger et al.,
1975). In addition Calvillo et al. (1974) in a preliminary 
communication reported that morphine depressed the sensitivity 
to L-glutamate only of those neurones which responded to 
noxious stimulation, and that intravenous naloxone reversed 
this effect on 2 of 4 occasions, while electrophoretically 
administered naloxone reversed this effect on only 2 of 7 
neurones. (See Chapter III (iii)).
The literature regarding the interaction between opiates 
and amino acid putative transmitters such as L-glutamate is 
relatively brief. There is neurochemical evidence (Sherman 
& Gebhart, 1974) that in mice, noxious stimulation, exposure 
to a hot plate, decreases the level of L-glutamate found in 
the peri-aqueductal grey region of mice, and that morphine prevents 
this change in a manner which is antagonized by prior admin­
istration of naloxone.
In conclusion then, the present investigations of medial 
thalamic neurones have shown that of the three types of 
firing pattern studied (spontaneous, and that produced by 
electrical stimulation of the forepaws or by L-glutamate),
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only that produced by electrophoretic administration of 
L-glutamate was found to be altered by low doses of intra­
venous morphine. The finding,that what might be anticipated 
as more conventionally tested patterns of neuronal activity 
were not susceptible to morphine,was unexpected, and it may 
be that the firing induced by L-glutamate is a more sensitive 
test of cell excitability. Further investigations might 
clarify the mechanism by which morphine selectively depresses 
the action of this substance, and whether this effect results 
in the depression of a particular neuronal or fibre population, 
perhaps those involved in the central organization of infor­
mation in nociceptive pathways.
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CHAPTER IV - THE USE OF SNAKE NEUROTOXINS FOR
IDENTIFICATION AND CHARACTERIZATION 
OF ACETYLCHOLINE RECEPTORS IN THE 
CENTRAL NERVOUS SYSTEM 
- A PHARMACOLOGICAL STUDY
Introduction
Since the isolation and characterization of 
a-bungarotoxin (Chang & Lee, 1963; Mebs, Narita, Iwanaga 
Samejima & Lee, 1971) and cobra neurotoxin (Lee et. al. ,
1968; Karlson, Arnberg & Eaker, 1971) these polypeptides 
have been widely used for their ability to bind to post- 
synaptic receptors for acetylcholine (Lee, Tseng & Chiu,
1967). The types of studies,utilizing the essentially 
irreversible binding properties of these purified snake 
toxins,include investigations of neuromuscular transmission 
(Chang & Lee, 1963; Miledi & Potter, 1971) and attempts to 
localize, isolate and characterize the receptor for acetyl­
choline in various tissues (Changeaux, Kasai & Lee, 1970; 
Miledi, Molinoff & Potter, 1971).
Although a-bungarotoxin and cobra neurotoxin do not 
pass the blood-brain barrier, and therefore do not enter the 
central nervous system to a measurable extent (Lee & Tseng, 
1966), several investigators have used these toxins in 
attempts to characterize, in vitro, acetylcholine receptors 
in the vertebrate brain (Salvaterra & Moore, 1973; Schleifer 
& Edelfrawi, 1974; Eterovic & Bennett, 1974; Polz-Tejera, 
Schmidt & Karten, 1975). Although binding activity of these 
toxins to brain preparations is highest in synaptosomal frac­
tions (Salvaterra & Moore, 1973), and is inhibited by various
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nicotinic compounds (Eterovic & Bennett, 1974), the signif­
icance of these findings is uncertain in the absence of 
knowledge of the effects of toxin on central nicotinic 
receptors in_ vivo.
In invertebrate preparations, a-bungarotoxin has been 
shown to antagonize the response to acetylcholine of these three 
types of central molluscan cholinergic receptors (Shain et al. , 
1974) but two subsequent reports (Szczepaniak, 1974; Kehoe 
et al. , 1976) found however,that a-bungarotoxin antagonized only
a cholinergic inhibitory mechanism which was chloride 
dependent.
In the cat, the nicotinic receptors of sympathetic ganglia 
are unaffected by locally injected cobra neurotoxin (Chou &
Lee, 1969) or a-bungarotoxin (Lee & Lee, unpublished). Obata 
(1974), working with cultured sympathetic ganglia and atrial 
muscle cells of the rat, demonstrated no antagonism of the 
responses to acetylcholine by a-bungaratoxin. In addition, 
the dorsal root potentials produced by stimulation of the 
ventral roots of the isolated frog spinal cord, a mechanism 
which involves a nicotinic cholinergic synapse (Kiraly &
Phillis, 1971) are not reduced by high concentrations of 
a-bungarotoxin (Miledi & Szczepaniak, 1975) .
In an attempt to resolve whether these neurotoxins were 
active at central receptors for acetylcholine in the cat, 
a-bungarotoxin (aBTX) and cobra neurotoxin (CTX) were 
administered from micropipettes in the vicinity of Renshaw 
cells. The synaptic activation of these neurones and their 
excitatory responses to acetylcholine and excitant amino acids 
administered from micropipettes were studied. Both 
a-bungarotoxin and cobra neurotoxin were administered by
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several different procedures as described in Methods
and all animals were anaesthetized with pentobarbitone sodium.
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RESULTS
The effects of the neurotoxins, administered both electro- 
phoretically and by pressure, on excitation by electro- 
phoretically administered excitants, were studied on 45 
Renshaw cells. With 16 of these, cholinergic synaptic 
activation was studied concurrently and with 3 neurones, 
synaptic activation alone was measured. The results are 
summarized in Table VIII.
Of the seven cells in which a reduction in sensitivity 
to electrophoretic acetylcholine occurred, cholinergic 
synaptic activation was studied in 5 and a reduction observed 
in only one. No reduction in synaptic activation was 
observed with the two cells in which sensitivity to L-glutamate 
declined following ejection of toxin. Recovery studies were 
incomplete, but with two cells in which a-bungarotoxin ejection 
was associated with a reduction in acetylcholine sensitivity, 
recovery was observed at 5 and 118 min, and with another no 
recovery was present 14 min after cessation of ejection.
Under the experimental conditions used, ejection of the 
two snake neurotoxins had no significant effect in reducing 
cholinergic synaptic activation of Renshaw cells. Indeed 
an enhanced response was observed with 4 of 19 neurones.
This probably resulted from the mechanical disturbances of 
ejection by pressure,as an increase in spontaneous firing 
was observed with all four cells immediately on application 
of pressure.
No significant effect on chemical sensitivity was 
observed following ejection of the neurotoxins. While a 
reduction in the response to an electrophoretic excitant
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occurred more commonly with acetylcholine than with 
L-glutamate, failure to observe a concurrent reduction in 
synaptic activation makes it probable that changing cell- 
pipette distances and not blockade of acetylcholine receptors 
was responsible for this result. Concentrations of dihydro- 
ß-erythroidine ejected by pressure and adequate to reduce the 
response to acetylcholine, also reduced ventral root evoked 
firing. The problems of quantitative measurements of 
chemical sensitivity outlined in Methods do not apply to 
synaptic activation and it was clear that this was unaffected 
by ejection of the neurotoxins.
To ensure that the lack of effects obtained with aBTX and 
CTX was not due to failure to spread from the site of pressure 
injection to surrounding areas of the nervous tissue, the 
distribution of radiolabelled aBTX and CTX, when ejected in 
the same manner, was subsequently studied. A similar study 
(Polz-Tejera, Schmidt & Karten, 1975) but using in vitro 
methods has reported that certain brain regions "bind" 
radiolabelled a-bungarotoxin better than others,but the 
precise cellular localization of binding was unable to be 
determined.
The potency of the a-bungarotoxin following the iodin- 
ation procedure was checked and the sample caused death within 
15 minutes of an I.P. injection of 0.60 ug/g of aBTX to a 
mouse (4LD50; Lee et a_l. , 1972). Insufficient radiolabelled
cobra neurotoxin was available for this test of potency.
12 5Autoradiographic analysis of the I-labelled compounds 
at various times after ejection showed that they diffused 
readily in the spinal cord. Even at 3h hours after injection, 
labelled toxin had extended to the edge of the largest block
Fig. 34: A. Labelling in the vicinity of end plates
of the diaphragm of a mouse killed by injection of 
radiolabelled a-bungarotoxin. B. Labelling of neurones 
in the lumbar spinal cord adjacent to an injection site 
of cobra-neurotoxin; seven hours between injection and 
fixation. C. Labelling of blood vessel walls but not 
spinal neurones following injection of a-bungarotoxin 
3h hours previously. The section was 2.1 mm from the 
injection site. D. Labelling of blood vessel walls but 
not spinal neurones following injection of cobra—neurotoxin 
4 hours previously. The section was 1.3 mm from the 
injection site. B & C from medial ventral horn; D, from 
lateral ventral horn. Calibration bar: 50 ym.
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of tissue i.e. greater than 2.2 mm from the injection site.
As the sections were 5 p thick, the cell membranes of 
most spinal neurones would be seen in outline. If extra­
cellular binding had occurred the resultant appearance could 
be expected to be an accumulation of silver grains outlining 
the body. Areas of cell body entirely within the plane of 
section, either cells cut obliquely or cell processes, would 
be uniformly labelled. As Renshaw cells have relatively 
small somata (10-15 p ; Jankowska & Lindstrom, 1971), 
uniform labelling would be commonly expected.
The diaphragm of the mouse used above to test the 
toxins' potency was found by autoradiographic examination to 
be highly labelled (Fig. 34A).
In spinal tissue sections, accumulations of silver grains 
were observed over two types of structures - neurones (Fig. 
34B) and blood vessel walls (Fig. 34C, D). The latter were 
commonly labelled, presumably as a result of the difficulty 
with which toxins penetrate capillary walls to the lumen.
Neurones on the other hand were labelled only in the 
vicinity of the injection sites and to a similar extent in 
both dorsal and ventral horns; no neuronal accumulations of 
grains were observed more than approximately 150 p from the 
injection site.
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DISCUSSION
From the results of the autoradiographic study, it is 
unlikely that the lack of effects of ejected toxins on Ren- 
shaw cell firing in response to synaptic and chemical acti- 
vation,was due to failure of spread from the injection site. 
Labelled aBTX has also been shown to penetrate readily the 
isolated frog spinal cord (Miledi & Szczepaniak, 1975).
Studies in which proteins have been ejected from micro­
pipettes are few, but it has been estimated from effects on 
adjacent neurones, that tetanus toxin injected into the cere­
bellar cortex of the cat from a pipette of tip diameter 25 Mm, 
spreads at a rate of 0.5-1.0 mm/hr (Curtis, Felix, Game & 
McCulloch, 1973). A similar rate of distribution has been 
found by the present investigations.
Although similarities have been noted between the effects 
on the rat cerebral cortex of locally applied strychnine, 
curare and a cobra neurotoxin fraction (Bhargava, Horton & 
Meldrum, 1970), in the cat the toxicity of intracisternal 
whole cobra venom has been attributed to cardiotoxin and 
phospholipase A and not to neurotoxin (Lee, 1971). A 
similar deduction has been made for the effects of cobra 
venom on ganglionic transmission in the cat (Chou & Lee, 1969). 
It has been proposed that the acetylcholine receptors of 
Renshaw cells have properties more related to those of sym­
pathetic ganglia than to skeletal muscle (Curtis & Ryall, 1966), 
a suggestion consistent with the failure of aBTX and CTX to 
block activation of Renshaw cells and ganglion cells.
The labelling of neurones in both dorsal and ventral 
horns and within only a very small distance from the
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injection sites,implies that it was a consequence of severance 
of neuronal processes by the penetrating micropipettes,with 
a resultant intracellular accumulation of toxin: the uniform
labelling of these cells, which could be observed in several 
serial sections, indicates an intracellular location of the 
toxin.
It is unlikely that the failure to observe silver grain 
accumulations indicating extracellular binding was due to the 
relatively high background,since such accumulations were 
readily detectable around blood vessels (Fig. 34C, D). 
Moreover, if the receptor density on the surface of neurones 
receiving a nicotinic innervation is comparable to that at 
mouse diaphragm end plates (Fig. 34A), then the grain density 
resulting from binding of labelled toxin should have been 
sufficiently above background to permit detection. The 
amounts of toxin expelled should have been adequate to 
saturate nicotinic receptors for a considerable distance 
from the injection site. In the case of aBTX,approximately 
0.46 pg was expelled at each site whereas 12.0 pg in the whole 
mouse (20g) produced heavy labelling of end plates.
The significance of the binding of these toxins to brain 
slices (Polz-Tejera, Schmidt & Karten, 1975) and homogenates 
(Eterovic & Bennett, 1974) is uncertain when considered with 
the present results. Intracellular binding of aBTX (Porter, 
Chui, Weikowski & Barnard, 1973) and of CTX (Libelius, 1975) 
has been demonstrated with mouse skeletal muscle and such 
sites are widely distributed and not related to end plates. 
Intracellular binding of [14C]nicotine has been demonstrated 
in rat brain slices (Alderice & Weiss, 1975). It is perhaps 
this binding which was observed when thin slices were
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incubated with aBTX.
These results from autoradiographic studies support 
those obtained from extracellular recording studies with 
Renshaw cells and together with other reports (Obata, 1974; 
Miledi & Szczepaniak, 1975; Lee & Lee, unpublished) render 
it unlikely that these toxins are useful markers for the 
presence, distribution and characterization of nicotinic 
receptors within the vertebrate central nervous system.
CHAPTER V CONCLUDING REMARKS
The results presented in this Thesis have provided 
evidence for an interaction of opiates, both at receptors 
for acetylcholine and at sites of unknown identity in the 
dorsal horn of the spinal cord. The apparent diversity of 
these findings warrants some concluding remarks.
The studies with Renshaw cells suggested that opiates 
may produce some of their effects by an action at nicotinic 
receptors for acetylcholine in the central nervous system. 
This possibility has been supported by the finding of similar 
effects of morphine at the mixed cholinergic receptors of 
ventro-basal thalamic neurones but not at those of the 
muscarinic receptors of the cerebral cortex (Duggan, Davies 
& Hall, 1976).
That naloxone administered electrophoretically reversed 
the excitation produced by similarly administered morphine at 
nicotinic receptors, was taken as evidence of the pharma­
cological specificity of morphine's effect and therefore of 
its possible relevance to systemic effects of opiates.
These results were supported by studies with morphinan com­
pounds, although significant differences between the effects 
of these and of morphine and naloxone could be observed. 
Studies with physostigmine failed to define the mechanism of 
action of the effect of morphine although a postsynaptic site 
was implicated. The results obtained with oxymorphone were 
not altogether consistent with an action of opiates at 
nicotinic receptors.
The later results, which demonstrated that morphine 
administered in the region of the substantia gelatinosa,
112
but not near cell bodies, produced a selective depression 
of the response of dorsal horn neurones to noxious stim­
ulation, have been interpreted as a relevant effect of this 
opiate, not only because of its selectivity in the modality 
affected but also because of its reversibility by similarly 
administered naloxone. The important claim to relevance 
of these later experiments is not reversibility by electro­
phoretic naloxone but the finding that low dosesof intra­
venous naloxone could produce reversal of the effect of 
morphine.
It is conceivable that an effect of a compound, when 
administered electrophoretically, becomes evident merely 
as a result of high enough concentrations of that compound 
at appropriate receptors. It is as equally conceivable 
that an antagonist, similarly administered, and in high 
concentrations,might antagonize such effects at the same 
receptors. This possibility may apply to the effects seen 
at nicotinic receptors of Renshaw cells in the initial studies. 
Therefore, it is desirable, for the argument of physiological 
relevance, to show that effects observed with one compound 
are reversible with low intravenous doses of its antagonist. 
Such a demonstration was possible with the studies where 
morphine was administered in the substantia gelatinosa region.
There is a vast literature concerning the site of action 
of morphine-like compounds and convincing evidence has been 
provided for an action both at the spinal level and at higher 
brain centres (spinal cord literature already discussed; 
Liebeskind, e_t a_l. , 1974; Dey & Feldberg, 1975). Clearly 
both sites are important and a modulating role by higher 
centres of spinal cord processes has been suggested (Satoh
113
& Takagi, 1971; Heavner, 1975). The results from the 
present study, with administration to the substantia gelat- 
inosa, suggest the importance of a spinal action of opiates.
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